1: GO: Molecular Function [Display Chart]
598 annotations before applied cutoff / 18819 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
GO:0005539
|
glycosaminoglycan binding
|
|
9.328E-17
|
5.578E-14
|
3.889E-13
|
5.578E-14
|
23
|
219
|
2
|
GO:0019838
|
growth factor binding
|
|
5.351E-16
|
1.600E-13
|
1.115E-12
|
3.200E-13
|
19
|
142
|
3
|
GO:0005201
|
extracellular matrix structural constituent
|
|
6.321E-14
|
1.260E-11
|
8.785E-11
|
3.780E-11
|
14
|
78
|
4
|
GO:0008201
|
heparin binding
|
|
2.180E-11
|
3.259E-9
|
2.272E-8
|
1.304E-8
|
16
|
167
|
5
|
GO:1901681
|
sulfur compound binding
|
|
3.247E-11
|
3.883E-9
|
2.707E-8
|
1.942E-8
|
19
|
260
|
6
|
GO:0048407
|
platelet-derived growth factor binding
|
|
1.037E-9
|
1.034E-7
|
7.205E-7
|
6.201E-7
|
6
|
12
|
7
|
GO:0001968
|
fibronectin binding
|
|
1.036E-6
|
8.850E-5
|
6.170E-4
|
6.195E-4
|
6
|
33
|
8
|
GO:0071837
|
HMG box domain binding
|
|
3.364E-6
|
2.515E-4
|
1.753E-3
|
2.012E-3
|
5
|
23
|
9
|
GO:0005518
|
collagen binding
|
|
9.927E-6
|
6.596E-4
|
4.598E-3
|
5.936E-3
|
7
|
72
|
10
|
GO:0043394
|
proteoglycan binding
|
|
2.932E-5
|
1.693E-3
|
1.180E-2
|
1.754E-2
|
5
|
35
|
11
|
GO:0050431
|
transforming growth factor beta binding
|
|
3.114E-5
|
1.693E-3
|
1.180E-2
|
1.862E-2
|
4
|
18
|
12
|
GO:0005534
|
galactose binding
|
|
3.776E-5
|
1.882E-3
|
1.312E-2
|
2.258E-2
|
3
|
7
|
13
|
GO:0019199
|
transmembrane receptor protein kinase activity
|
|
4.618E-5
|
2.124E-3
|
1.481E-2
|
2.761E-2
|
7
|
91
|
14
|
GO:0031995
|
insulin-like growth factor II binding
|
|
5.995E-5
|
2.561E-3
|
1.785E-2
|
3.585E-2
|
3
|
8
|
15
|
GO:0038049
|
transcription factor activity, ligand-activated RNA polymerase II transcription factor binding
|
|
1.079E-4
|
4.303E-3
|
3.000E-2
|
6.454E-2
|
2
|
2
|
16
|
GO:0005044
|
scavenger receptor activity
|
|
1.252E-4
|
4.450E-3
|
3.102E-2
|
7.488E-2
|
5
|
47
|
17
|
GO:0005024
|
transforming growth factor beta-activated receptor activity
|
|
1.265E-4
|
4.450E-3
|
3.102E-2
|
7.565E-2
|
3
|
10
|
18
|
GO:0005520
|
insulin-like growth factor binding
|
|
1.921E-4
|
6.381E-3
|
4.449E-2
|
1.149E-1
|
4
|
28
|
19
|
GO:0031994
|
insulin-like growth factor I binding
|
|
2.284E-4
|
7.188E-3
|
5.011E-2
|
1.366E-1
|
3
|
12
|
20
|
GO:0001948
|
glycoprotein binding
|
|
2.634E-4
|
7.876E-3
|
5.491E-2
|
1.575E-1
|
7
|
120
|
21
|
GO:0005178
|
integrin binding
|
|
2.915E-4
|
8.012E-3
|
5.586E-2
|
1.743E-1
|
7
|
122
|
22
|
GO:0050840
|
extracellular matrix binding
|
|
3.142E-4
|
8.012E-3
|
5.586E-2
|
1.879E-1
|
5
|
57
|
23
|
GO:0035373
|
chondroitin sulfate proteoglycan binding
|
|
3.215E-4
|
8.012E-3
|
5.586E-2
|
1.923E-1
|
2
|
3
|
24
|
GO:0004096
|
catalase activity
|
|
3.215E-4
|
8.012E-3
|
5.586E-2
|
1.923E-1
|
2
|
3
|
25
|
GO:0050839
|
cell adhesion molecule binding
|
|
3.532E-4
|
8.449E-3
|
5.890E-2
|
2.112E-1
|
9
|
209
|
26
|
GO:0001077
|
transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding
|
|
3.991E-4
|
9.179E-3
|
6.399E-2
|
2.387E-1
|
10
|
259
|
27
|
GO:0019955
|
cytokine binding
|
|
7.318E-4
|
1.621E-2
|
1.130E-1
|
4.376E-1
|
6
|
103
|
28
|
GO:0038024
|
cargo receptor activity
|
|
8.688E-4
|
1.822E-2
|
1.270E-1
|
5.196E-1
|
5
|
71
|
29
|
GO:0004857
|
enzyme inhibitor activity
|
|
8.836E-4
|
1.822E-2
|
1.270E-1
|
5.284E-1
|
12
|
393
|
30
|
GO:0038085
|
vascular endothelial growth factor binding
|
|
1.057E-3
|
2.107E-2
|
1.469E-1
|
6.322E-1
|
2
|
5
|
31
|
GO:0004222
|
metalloendopeptidase activity
|
|
1.187E-3
|
2.290E-2
|
1.596E-1
|
7.098E-1
|
6
|
113
|
32
|
GO:0046332
|
SMAD binding
|
|
1.254E-3
|
2.343E-2
|
1.634E-1
|
7.498E-1
|
5
|
77
|
33
|
GO:0048029
|
monosaccharide binding
|
|
1.488E-3
|
2.696E-2
|
1.880E-1
|
8.897E-1
|
5
|
80
|
34
|
GO:0004675
|
transmembrane receptor protein serine/threonine kinase activity
|
|
1.916E-3
|
3.371E-2
|
2.350E-1
|
1.000E0
|
3
|
24
|
35
|
GO:0004866
|
endopeptidase inhibitor activity
|
|
2.129E-3
|
3.638E-2
|
2.536E-1
|
1.000E0
|
7
|
171
|
36
|
GO:0061134
|
peptidase regulator activity
|
|
2.392E-3
|
3.973E-2
|
2.770E-1
|
1.000E0
|
8
|
223
|
37
|
GO:0061135
|
endopeptidase regulator activity
|
|
2.584E-3
|
4.177E-2
|
2.912E-1
|
1.000E0
|
7
|
177
|
38
|
GO:0030414
|
peptidase inhibitor activity
|
|
2.838E-3
|
4.467E-2
|
3.114E-1
|
1.000E0
|
7
|
180
|
39
|
GO:0004175
|
endopeptidase activity
|
|
3.114E-3
|
4.774E-2
|
3.328E-1
|
1.000E0
|
12
|
457
|
40
|
GO:0004867
|
serine-type endopeptidase inhibitor activity
|
|
3.310E-3
|
4.920E-2
|
3.430E-1
|
1.000E0
|
5
|
96
|
41
|
GO:0030246
|
carbohydrate binding
|
|
3.454E-3
|
4.920E-2
|
3.430E-1
|
1.000E0
|
9
|
290
|
42
|
GO:0008237
|
metallopeptidase activity
|
|
3.609E-3
|
4.920E-2
|
3.430E-1
|
1.000E0
|
7
|
188
|
43
|
GO:0043208
|
glycosphingolipid binding
|
|
3.703E-3
|
4.920E-2
|
3.430E-1
|
1.000E0
|
2
|
9
|
44
|
GO:0032052
|
bile acid binding
|
|
3.703E-3
|
4.920E-2
|
3.430E-1
|
1.000E0
|
2
|
9
|
45
|
GO:0052650
|
NADP-retinol dehydrogenase activity
|
|
3.703E-3
|
4.920E-2
|
3.430E-1
|
1.000E0
|
2
|
9
|
Show 40 more annotations
|
2: GO: Biological Process [Display Chart]
3413 annotations before applied cutoff / 18785 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
GO:0030198
|
extracellular matrix organization
|
|
1.006E-28
|
1.913E-25
|
1.667E-24
|
3.434E-25
|
39
|
354
|
2
|
GO:0043062
|
extracellular structure organization
|
|
1.121E-28
|
1.913E-25
|
1.667E-24
|
3.826E-25
|
39
|
355
|
3
|
GO:0001503
|
ossification
|
|
1.372E-13
|
1.561E-10
|
1.360E-9
|
4.682E-10
|
26
|
406
|
4
|
GO:0022617
|
extracellular matrix disassembly
|
|
1.264E-11
|
1.079E-8
|
9.398E-8
|
4.315E-8
|
13
|
92
|
5
|
GO:0030574
|
collagen catabolic process
|
|
9.298E-11
|
6.347E-8
|
5.530E-7
|
3.173E-7
|
11
|
67
|
6
|
GO:0048706
|
embryonic skeletal system development
|
|
1.751E-10
|
9.961E-8
|
8.679E-7
|
5.977E-7
|
14
|
137
|
7
|
GO:0044243
|
multicellular organismal catabolic process
|
|
2.838E-10
|
1.384E-7
|
1.206E-6
|
9.688E-7
|
11
|
74
|
8
|
GO:0048705
|
skeletal system morphogenesis
|
|
4.442E-10
|
1.795E-7
|
1.564E-6
|
1.516E-6
|
17
|
235
|
9
|
GO:0032963
|
collagen metabolic process
|
|
4.734E-10
|
1.795E-7
|
1.564E-6
|
1.616E-6
|
13
|
122
|
10
|
GO:0035987
|
endodermal cell differentiation
|
|
7.812E-10
|
2.431E-7
|
2.118E-6
|
2.666E-6
|
9
|
45
|
11
|
GO:0044259
|
multicellular organismal macromolecule metabolic process
|
|
7.834E-10
|
2.431E-7
|
2.118E-6
|
2.674E-6
|
13
|
127
|
12
|
GO:0050673
|
epithelial cell proliferation
|
|
1.034E-9
|
2.940E-7
|
2.562E-6
|
3.528E-6
|
21
|
394
|
13
|
GO:0007492
|
endoderm development
|
|
2.444E-9
|
6.416E-7
|
5.590E-6
|
8.341E-6
|
11
|
90
|
14
|
GO:0044236
|
multicellular organism metabolic process
|
|
4.041E-9
|
9.852E-7
|
8.584E-6
|
1.379E-5
|
13
|
145
|
15
|
GO:0001706
|
endoderm formation
|
|
6.050E-9
|
1.377E-6
|
1.199E-5
|
2.065E-5
|
9
|
56
|
16
|
GO:0031589
|
cell-substrate adhesion
|
|
9.054E-9
|
1.931E-6
|
1.683E-5
|
3.090E-5
|
18
|
324
|
17
|
GO:0048562
|
embryonic organ morphogenesis
|
|
1.045E-8
|
2.097E-6
|
1.827E-5
|
3.566E-5
|
18
|
327
|
18
|
GO:0048704
|
embryonic skeletal system morphogenesis
|
|
1.154E-8
|
2.188E-6
|
1.907E-5
|
3.939E-5
|
11
|
104
|
19
|
GO:0001101
|
response to acid chemical
|
|
1.346E-8
|
2.379E-6
|
2.073E-5
|
4.594E-5
|
19
|
372
|
20
|
GO:0001649
|
osteoblast differentiation
|
|
1.394E-8
|
2.379E-6
|
2.073E-5
|
4.758E-5
|
15
|
224
|
21
|
GO:0071560
|
cellular response to transforming growth factor beta stimulus
|
|
2.106E-8
|
3.423E-6
|
2.983E-5
|
7.189E-5
|
15
|
231
|
22
|
GO:0007178
|
transmembrane receptor protein serine/threonine kinase signaling pathway
|
|
2.495E-8
|
3.871E-6
|
3.373E-5
|
8.516E-5
|
18
|
346
|
23
|
GO:0071559
|
response to transforming growth factor beta
|
|
2.649E-8
|
3.931E-6
|
3.425E-5
|
9.041E-5
|
15
|
235
|
24
|
GO:0090287
|
regulation of cellular response to growth factor stimulus
|
|
8.208E-8
|
1.167E-5
|
1.017E-4
|
2.801E-4
|
15
|
256
|
25
|
GO:0001525
|
angiogenesis
|
|
9.459E-8
|
1.291E-5
|
1.125E-4
|
3.228E-4
|
20
|
465
|
26
|
GO:0060348
|
bone development
|
|
1.396E-7
|
1.832E-5
|
1.597E-4
|
4.764E-4
|
13
|
195
|
27
|
GO:0051216
|
cartilage development
|
|
1.667E-7
|
2.087E-5
|
1.818E-4
|
5.690E-4
|
13
|
198
|
28
|
GO:0060324
|
face development
|
|
1.712E-7
|
2.087E-5
|
1.818E-4
|
5.844E-4
|
8
|
59
|
29
|
GO:1904888
|
cranial skeletal system development
|
|
2.542E-7
|
2.991E-5
|
2.606E-4
|
8.675E-4
|
8
|
62
|
30
|
GO:0071229
|
cellular response to acid chemical
|
|
2.636E-7
|
2.999E-5
|
2.613E-4
|
8.997E-4
|
13
|
206
|
31
|
GO:0030199
|
collagen fibril organization
|
|
3.343E-7
|
3.610E-5
|
3.146E-4
|
1.141E-3
|
7
|
44
|
32
|
GO:0050678
|
regulation of epithelial cell proliferation
|
|
3.385E-7
|
3.610E-5
|
3.146E-4
|
1.155E-3
|
16
|
326
|
33
|
GO:0071230
|
cellular response to amino acid stimulus
|
|
3.694E-7
|
3.821E-5
|
3.329E-4
|
1.261E-3
|
8
|
65
|
34
|
GO:1903224
|
regulation of endodermal cell differentiation
|
|
3.926E-7
|
3.940E-5
|
3.433E-4
|
1.340E-3
|
4
|
7
|
35
|
GO:0035239
|
tube morphogenesis
|
|
4.069E-7
|
3.940E-5
|
3.433E-4
|
1.389E-3
|
18
|
417
|
36
|
GO:0060021
|
palate development
|
|
4.156E-7
|
3.940E-5
|
3.433E-4
|
1.419E-3
|
9
|
90
|
37
|
GO:0001822
|
kidney development
|
|
4.685E-7
|
4.322E-5
|
3.765E-4
|
1.599E-3
|
15
|
293
|
38
|
GO:0048771
|
tissue remodeling
|
|
5.109E-7
|
4.588E-5
|
3.998E-4
|
1.744E-3
|
12
|
183
|
39
|
GO:0048645
|
animal organ formation
|
|
5.906E-7
|
5.153E-5
|
4.490E-4
|
2.016E-3
|
8
|
69
|
40
|
GO:0060349
|
bone morphogenesis
|
|
6.039E-7
|
5.153E-5
|
4.490E-4
|
2.061E-3
|
9
|
94
|
41
|
GO:0061138
|
morphogenesis of a branching epithelium
|
|
6.201E-7
|
5.162E-5
|
4.498E-4
|
2.116E-3
|
13
|
222
|
42
|
GO:0040017
|
positive regulation of locomotion
|
|
6.687E-7
|
5.434E-5
|
4.735E-4
|
2.282E-3
|
19
|
478
|
43
|
GO:0048568
|
embryonic organ development
|
|
7.817E-7
|
6.204E-5
|
5.406E-4
|
2.668E-3
|
19
|
483
|
44
|
GO:0061448
|
connective tissue development
|
|
8.994E-7
|
6.977E-5
|
6.079E-4
|
3.070E-3
|
14
|
268
|
45
|
GO:0048701
|
embryonic cranial skeleton morphogenesis
|
|
9.495E-7
|
7.201E-5
|
6.274E-4
|
3.241E-3
|
7
|
51
|
46
|
GO:0072001
|
renal system development
|
|
9.937E-7
|
7.373E-5
|
6.424E-4
|
3.392E-3
|
15
|
311
|
47
|
GO:0043200
|
response to amino acid
|
|
1.019E-6
|
7.400E-5
|
6.448E-4
|
3.478E-3
|
10
|
129
|
48
|
GO:0030335
|
positive regulation of cell migration
|
|
1.074E-6
|
7.639E-5
|
6.656E-4
|
3.667E-3
|
18
|
446
|
49
|
GO:0001655
|
urogenital system development
|
|
1.171E-6
|
8.154E-5
|
7.104E-4
|
3.995E-3
|
16
|
358
|
50
|
GO:0001763
|
morphogenesis of a branching structure
|
|
1.358E-6
|
9.270E-5
|
8.076E-4
|
4.635E-3
|
13
|
238
|
Show 45 more annotations
|
3: GO: Cellular Component [Display Chart]
278 annotations before applied cutoff / 19172 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
GO:0031012
|
extracellular matrix
|
|
1.691E-29
|
4.702E-27
|
2.919E-26
|
4.702E-27
|
43
|
444
|
2
|
GO:0005578
|
proteinaceous extracellular matrix
|
|
1.298E-26
|
1.805E-24
|
1.120E-23
|
3.609E-24
|
38
|
379
|
3
|
GO:0044420
|
extracellular matrix component
|
|
2.016E-22
|
1.869E-20
|
1.160E-19
|
5.606E-20
|
24
|
143
|
4
|
GO:0098644
|
complex of collagen trimers
|
|
8.032E-13
|
5.582E-11
|
3.465E-10
|
2.233E-10
|
9
|
23
|
5
|
GO:0005604
|
basement membrane
|
|
8.649E-12
|
4.809E-10
|
2.985E-9
|
2.404E-9
|
14
|
111
|
6
|
GO:0005581
|
collagen trimer
|
|
1.090E-10
|
5.049E-9
|
3.134E-8
|
3.030E-8
|
12
|
88
|
7
|
GO:0005583
|
fibrillar collagen trimer
|
|
9.870E-10
|
3.430E-8
|
2.129E-7
|
2.744E-7
|
6
|
12
|
8
|
GO:0098643
|
banded collagen fibril
|
|
9.870E-10
|
3.430E-8
|
2.129E-7
|
2.744E-7
|
6
|
12
|
9
|
GO:0005589
|
collagen type VI trimer
|
|
1.085E-6
|
3.016E-5
|
1.872E-4
|
3.016E-4
|
3
|
3
|
10
|
GO:0098647
|
collagen beaded filament
|
|
1.085E-6
|
3.016E-5
|
1.872E-4
|
3.016E-4
|
3
|
3
|
11
|
GO:0005788
|
endoplasmic reticulum lumen
|
|
6.037E-5
|
1.526E-3
|
9.470E-3
|
1.678E-2
|
10
|
207
|
12
|
GO:0005584
|
collagen type I trimer
|
|
1.061E-4
|
2.459E-3
|
1.526E-2
|
2.950E-2
|
2
|
2
|
13
|
GO:0031091
|
platelet alpha granule
|
|
1.253E-4
|
2.679E-3
|
1.663E-2
|
3.483E-2
|
6
|
75
|
14
|
GO:0031093
|
platelet alpha granule lumen
|
|
2.556E-4
|
4.884E-3
|
3.031E-2
|
7.104E-2
|
5
|
55
|
15
|
GO:0043202
|
lysosomal lumen
|
|
3.018E-4
|
4.884E-3
|
3.031E-2
|
8.391E-2
|
6
|
88
|
16
|
GO:0005606
|
laminin-1 complex
|
|
3.162E-4
|
4.884E-3
|
3.031E-2
|
8.791E-2
|
2
|
3
|
17
|
GO:0005588
|
collagen type V trimer
|
|
3.162E-4
|
4.884E-3
|
3.031E-2
|
8.791E-2
|
2
|
3
|
18
|
GO:0043259
|
laminin-10 complex
|
|
3.162E-4
|
4.884E-3
|
3.031E-2
|
8.791E-2
|
2
|
3
|
19
|
GO:0070022
|
transforming growth factor beta receptor complex
|
|
6.281E-4
|
9.190E-3
|
5.704E-2
|
1.746E-1
|
2
|
4
|
20
|
GO:0031983
|
vesicle lumen
|
|
8.990E-4
|
1.250E-2
|
7.756E-2
|
2.499E-1
|
6
|
108
|
21
|
GO:0005775
|
vacuolar lumen
|
|
1.303E-3
|
1.724E-2
|
1.070E-1
|
3.621E-1
|
6
|
116
|
22
|
GO:0005605
|
basal lamina
|
|
1.650E-3
|
2.085E-2
|
1.294E-1
|
4.587E-1
|
3
|
23
|
23
|
GO:0034774
|
secretory granule lumen
|
|
1.878E-3
|
2.270E-2
|
1.409E-1
|
5.221E-1
|
5
|
85
|
24
|
GO:0043256
|
laminin complex
|
|
2.852E-3
|
3.304E-2
|
2.051E-1
|
7.929E-1
|
2
|
8
|
25
|
GO:0005796
|
Golgi lumen
|
|
3.195E-3
|
3.553E-2
|
2.205E-1
|
8.882E-1
|
5
|
96
|
26
|
GO:0072562
|
blood microparticle
|
|
3.731E-3
|
3.989E-2
|
2.476E-1
|
1.000E0
|
6
|
143
|
27
|
GO:0060205
|
cytoplasmic vesicle lumen
|
|
4.500E-3
|
4.490E-2
|
2.787E-1
|
1.000E0
|
5
|
104
|
28
|
GO:0001527
|
microfibril
|
|
4.522E-3
|
4.490E-2
|
2.787E-1
|
1.000E0
|
2
|
10
|
29
|
GO:0042383
|
sarcolemma
|
|
5.181E-3
|
4.967E-2
|
3.083E-1
|
1.000E0
|
6
|
153
|
Show 24 more annotations
|
4: Human Phenotype [Display Chart]
951 annotations before applied cutoff / 4410 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
HP:0001388
|
Joint laxity
|
|
2.223E-8
|
1.389E-5
|
1.033E-4
|
2.114E-5
|
12
|
95
|
2
|
HP:0000977
|
Soft skin {has synonym type="layperson"}
|
|
2.922E-8
|
1.389E-5
|
1.033E-4
|
2.779E-5
|
7
|
22
|
3
|
HP:0001058
|
Poor wound healing {has synonym type="layperson"}
|
|
5.063E-8
|
1.605E-5
|
1.193E-4
|
4.815E-5
|
5
|
8
|
4
|
HP:0001073
|
Cigarette-paper scars {has synonym type="layperson"}
|
|
3.049E-7
|
5.989E-5
|
4.453E-4
|
2.900E-4
|
4
|
5
|
5
|
HP:0000974
|
Hyperextensible skin
|
|
3.149E-7
|
5.989E-5
|
4.453E-4
|
2.994E-4
|
7
|
30
|
6
|
HP:0000592
|
Blue sclerae
|
|
4.049E-7
|
6.418E-5
|
4.772E-4
|
3.851E-4
|
8
|
45
|
7
|
HP:0000993
|
Molluscoid pseudotumors
|
|
9.037E-7
|
1.228E-4
|
9.128E-4
|
8.594E-4
|
4
|
6
|
8
|
HP:0000978
|
Bruising susceptibility {has synonym type="layperson"}
|
|
1.642E-6
|
1.952E-4
|
1.452E-3
|
1.562E-3
|
9
|
72
|
9
|
HP:0002010
|
Narrow maxilla
|
|
4.001E-6
|
3.345E-4
|
2.487E-3
|
3.805E-3
|
3
|
3
|
10
|
HP:0005100
|
Premature birth following premature rupture of fetal membranes
|
|
4.001E-6
|
3.345E-4
|
2.487E-3
|
3.805E-3
|
3
|
3
|
11
|
HP:0005222
|
Bowel diverticulosis
|
|
4.001E-6
|
3.345E-4
|
2.487E-3
|
3.805E-3
|
3
|
3
|
12
|
HP:0001634
|
Mitral valve prolapse
|
|
4.220E-6
|
3.345E-4
|
2.487E-3
|
4.013E-3
|
7
|
43
|
13
|
HP:0000023
|
Inguinal hernia
|
|
5.852E-6
|
4.281E-4
|
3.183E-3
|
5.566E-3
|
11
|
131
|
14
|
HP:0001763
|
Pes planus
|
|
9.864E-6
|
6.700E-4
|
4.982E-3
|
9.380E-3
|
9
|
89
|
15
|
HP:0006316
|
Irregularly spaced teeth {has synonym type="layperson"}
|
|
1.582E-5
|
9.403E-4
|
6.991E-3
|
1.504E-2
|
3
|
4
|
16
|
HP:0005758
|
Basilar impression
|
|
1.582E-5
|
9.403E-4
|
6.991E-3
|
1.504E-2
|
3
|
4
|
17
|
HP:0002758
|
Osteoarthritis
|
|
1.997E-5
|
1.117E-3
|
8.308E-3
|
1.900E-2
|
5
|
22
|
18
|
HP:0001156
|
Brachydactyly syndrome
|
|
3.310E-5
|
1.749E-3
|
1.300E-2
|
3.148E-2
|
11
|
157
|
19
|
HP:0003304
|
Spondylolysis
|
|
3.909E-5
|
1.957E-3
|
1.455E-2
|
3.718E-2
|
3
|
5
|
20
|
HP:0001373
|
Joint dislocation {has synonym type="layperson"}
|
|
5.469E-5
|
2.601E-3
|
1.934E-2
|
5.201E-2
|
4
|
14
|
21
|
HP:0000394
|
Lop ear
|
|
7.728E-5
|
3.379E-3
|
2.512E-2
|
7.349E-2
|
3
|
6
|
22
|
HP:0000939
|
Osteoporosis
|
|
7.817E-5
|
3.379E-3
|
2.512E-2
|
7.434E-2
|
9
|
115
|
23
|
HP:0002645
|
Wormian bones
|
|
8.252E-5
|
3.412E-3
|
2.537E-2
|
7.847E-2
|
5
|
29
|
24
|
HP:0011001
|
Increased bone mineral density {has synonym type="layperson"}
|
|
1.254E-4
|
4.967E-3
|
3.693E-2
|
1.192E-1
|
4
|
17
|
25
|
HP:0002644
|
Abnormality of pelvic girdle bone morphology
|
|
1.816E-4
|
6.909E-3
|
5.137E-2
|
1.727E-1
|
5
|
34
|
26
|
HP:0006480
|
Premature loss of teeth
|
|
1.992E-4
|
7.288E-3
|
5.419E-2
|
1.895E-1
|
4
|
19
|
27
|
HP:0005897
|
Severe generalized osteoporosis
|
|
2.556E-4
|
7.596E-3
|
5.648E-2
|
2.431E-1
|
2
|
2
|
28
|
HP:0006086
|
Thin metacarpal cortices
|
|
2.556E-4
|
7.596E-3
|
5.648E-2
|
2.431E-1
|
2
|
2
|
29
|
HP:0005623
|
Absent ossification of calvaria
|
|
2.556E-4
|
7.596E-3
|
5.648E-2
|
2.431E-1
|
2
|
2
|
30
|
HP:0005005
|
Femoral bowing present at birth, straightening with time
|
|
2.556E-4
|
7.596E-3
|
5.648E-2
|
2.431E-1
|
2
|
2
|
31
|
HP:0008780
|
Congenital bilateral hip dislocation
|
|
2.556E-4
|
7.596E-3
|
5.648E-2
|
2.431E-1
|
2
|
2
|
32
|
HP:0003321
|
Biconcave flattened vertebrae
|
|
2.556E-4
|
7.596E-3
|
5.648E-2
|
2.431E-1
|
2
|
2
|
33
|
HP:0003077
|
Hyperlipidemia
|
|
3.003E-4
|
8.653E-3
|
6.434E-2
|
2.855E-1
|
4
|
21
|
34
|
HP:0003179
|
Protrusio acetabuli
|
|
3.135E-4
|
8.768E-3
|
6.519E-2
|
2.981E-1
|
3
|
9
|
35
|
HP:0001083
|
Ectopia lentis
|
|
3.625E-4
|
9.577E-3
|
7.121E-2
|
3.448E-1
|
4
|
22
|
36
|
HP:0001030
|
Fragile skin {has synonym type="layperson"}
|
|
3.625E-4
|
9.577E-3
|
7.121E-2
|
3.448E-1
|
4
|
22
|
37
|
HP:0002688
|
Absent frontal sinuses
|
|
4.426E-4
|
1.108E-2
|
8.236E-2
|
4.209E-1
|
3
|
10
|
38
|
HP:0002616
|
Aortic root dilatation
|
|
4.426E-4
|
1.108E-2
|
8.236E-2
|
4.209E-1
|
3
|
10
|
39
|
HP:0000765
|
Abnormality of the thorax
|
|
5.140E-4
|
1.253E-2
|
9.319E-2
|
4.888E-1
|
4
|
24
|
40
|
HP:0004349
|
Reduced bone mineral density
|
|
7.588E-4
|
1.503E-2
|
1.118E-1
|
7.216E-1
|
2
|
3
|
41
|
HP:0006460
|
Increased laxity of ankles
|
|
7.588E-4
|
1.503E-2
|
1.118E-1
|
7.216E-1
|
2
|
3
|
42
|
HP:0003023
|
Bowing of limbs due to multiple fractures
|
|
7.588E-4
|
1.503E-2
|
1.118E-1
|
7.216E-1
|
2
|
3
|
43
|
HP:0000923
|
Beaded ribs
|
|
7.588E-4
|
1.503E-2
|
1.118E-1
|
7.216E-1
|
2
|
3
|
44
|
HP:0006367
|
Crumpled long bones {has synonym type="layperson"}
|
|
7.588E-4
|
1.503E-2
|
1.118E-1
|
7.216E-1
|
2
|
3
|
45
|
HP:0008007
|
Primary congenital glaucoma
|
|
7.588E-4
|
1.503E-2
|
1.118E-1
|
7.216E-1
|
2
|
3
|
46
|
HP:0005072
|
Hyperextensibility at wrists
|
|
7.588E-4
|
1.503E-2
|
1.118E-1
|
7.216E-1
|
2
|
3
|
47
|
HP:0006149
|
Increased laxity of fingers
|
|
7.588E-4
|
1.503E-2
|
1.118E-1
|
7.216E-1
|
2
|
3
|
48
|
HP:0004474
|
Persistent open anterior fontanelle
|
|
7.588E-4
|
1.503E-2
|
1.118E-1
|
7.216E-1
|
2
|
3
|
49
|
HP:0004586
|
Biconcave vertebral bodies
|
|
7.929E-4
|
1.508E-2
|
1.121E-1
|
7.541E-1
|
3
|
12
|
50
|
HP:0000925
|
Abnormality of the vertebral column {has synonym type="layperson"}
|
|
7.929E-4
|
1.508E-2
|
1.121E-1
|
7.541E-1
|
3
|
12
|
Show 45 more annotations
|
5: Mouse Phenotype [Display Chart]
3461 annotations before applied cutoff / 9299 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
MP:0000163
|
abnormal cartilage morphology
|
|
1.307E-13
|
4.524E-10
|
3.948E-9
|
4.524E-10
|
31
|
381
|
2
|
MP:0000130
|
abnormal trabecular bone morphology
|
|
8.533E-12
|
1.477E-8
|
1.289E-7
|
2.953E-8
|
25
|
286
|
3
|
MP:0008271
|
abnormal bone ossification
|
|
1.595E-11
|
1.841E-8
|
1.606E-7
|
5.522E-8
|
30
|
428
|
4
|
MP:0002113
|
abnormal skeleton development
|
|
2.427E-11
|
2.100E-8
|
1.833E-7
|
8.401E-8
|
32
|
494
|
5
|
MP:0002115
|
abnormal limb bone morphology
|
|
4.125E-11
|
2.855E-8
|
2.492E-7
|
1.428E-7
|
31
|
474
|
6
|
MP:0011504
|
abnormal limb long bone morphology
|
|
6.238E-11
|
3.599E-8
|
3.140E-7
|
2.159E-7
|
30
|
452
|
7
|
MP:0000454
|
abnormal jaw morphology
|
|
2.236E-10
|
1.105E-7
|
9.647E-7
|
7.738E-7
|
29
|
446
|
8
|
MP:0003797
|
abnormal compact bone morphology
|
|
4.434E-10
|
1.918E-7
|
1.674E-6
|
1.535E-6
|
18
|
171
|
9
|
MP:0005503
|
abnormal tendon morphology
|
|
5.536E-10
|
2.129E-7
|
1.858E-6
|
1.916E-6
|
10
|
39
|
10
|
MP:0004686
|
decreased length of long bones
|
|
1.124E-9
|
3.890E-7
|
3.395E-6
|
3.890E-6
|
24
|
331
|
11
|
MP:0000556
|
abnormal hindlimb morphology
|
|
4.336E-9
|
1.185E-6
|
1.034E-5
|
1.501E-5
|
26
|
413
|
12
|
MP:0008438
|
abnormal cutaneous collagen fibril morphology
|
|
4.451E-9
|
1.185E-6
|
1.034E-5
|
1.540E-5
|
8
|
25
|
13
|
MP:0003089
|
decreased skin tensile strength
|
|
4.451E-9
|
1.185E-6
|
1.034E-5
|
1.540E-5
|
8
|
25
|
14
|
MP:0000458
|
abnormal mandible morphology
|
|
8.350E-9
|
2.064E-6
|
1.801E-5
|
2.890E-5
|
18
|
205
|
15
|
MP:0005275
|
abnormal skin tensile strength
|
|
1.668E-8
|
3.850E-6
|
3.359E-5
|
5.774E-5
|
8
|
29
|
16
|
MP:0010876
|
decreased bone volume
|
|
2.884E-8
|
6.238E-6
|
5.444E-5
|
9.981E-5
|
12
|
90
|
17
|
MP:0002932
|
abnormal joint morphology
|
|
4.489E-8
|
8.406E-6
|
7.335E-5
|
1.554E-4
|
21
|
310
|
18
|
MP:0000074
|
abnormal neurocranium morphology
|
|
4.605E-8
|
8.406E-6
|
7.335E-5
|
1.594E-4
|
19
|
255
|
19
|
MP:0005197
|
abnormal uvea morphology
|
|
4.614E-8
|
8.406E-6
|
7.335E-5
|
1.597E-4
|
16
|
179
|
20
|
MP:0010874
|
abnormal bone volume
|
|
5.569E-8
|
9.637E-6
|
8.410E-5
|
1.927E-4
|
15
|
158
|
21
|
MP:0003935
|
abnormal craniofacial development
|
|
8.178E-8
|
1.348E-5
|
1.176E-4
|
2.831E-4
|
23
|
381
|
22
|
MP:0002989
|
small kidney
|
|
9.676E-8
|
1.522E-5
|
1.328E-4
|
3.349E-4
|
18
|
240
|
23
|
MP:0002100
|
abnormal tooth morphology
|
|
1.121E-7
|
1.688E-5
|
1.473E-4
|
3.881E-4
|
17
|
216
|
24
|
MP:0010869
|
decreased bone trabecula number
|
|
1.246E-7
|
1.797E-5
|
1.568E-4
|
4.313E-4
|
10
|
66
|
25
|
MP:0009888
|
palatal shelves fail to meet at midline
|
|
1.392E-7
|
1.927E-5
|
1.682E-4
|
4.818E-4
|
9
|
51
|
26
|
MP:0005306
|
abnormal phalanx morphology
|
|
1.946E-7
|
2.590E-5
|
2.260E-4
|
6.734E-4
|
11
|
87
|
27
|
MP:0000550
|
abnormal forelimb morphology
|
|
3.249E-7
|
4.102E-5
|
3.580E-4
|
1.125E-3
|
16
|
206
|
28
|
MP:0009887
|
abnormal palatal shelf fusion at midline
|
|
3.319E-7
|
4.102E-5
|
3.580E-4
|
1.149E-3
|
10
|
73
|
29
|
MP:0020040
|
decreased bone ossification
|
|
3.813E-7
|
4.551E-5
|
3.972E-4
|
1.320E-3
|
8
|
42
|
30
|
MP:0000455
|
abnormal maxilla morphology
|
|
4.694E-7
|
5.416E-5
|
4.726E-4
|
1.625E-3
|
14
|
161
|
31
|
MP:0006395
|
abnormal epiphyseal plate morphology
|
|
6.575E-7
|
7.340E-5
|
6.406E-4
|
2.276E-3
|
16
|
217
|
32
|
MP:0003855
|
abnormal forelimb zeugopod morphology
|
|
7.881E-7
|
8.523E-5
|
7.438E-4
|
2.727E-3
|
12
|
121
|
33
|
MP:0010029
|
abnormal basicranium morphology
|
|
1.004E-6
|
1.053E-4
|
9.191E-4
|
3.475E-3
|
10
|
82
|
34
|
MP:0003055
|
abnormal long bone epiphyseal plate morphology
|
|
1.064E-6
|
1.083E-4
|
9.454E-4
|
3.683E-3
|
15
|
198
|
35
|
MP:0004540
|
small maxilla
|
|
1.556E-6
|
1.539E-4
|
1.343E-3
|
5.386E-3
|
9
|
67
|
36
|
MP:0005006
|
abnormal osteoblast physiology
|
|
2.005E-6
|
1.927E-4
|
1.682E-3
|
6.938E-3
|
9
|
69
|
37
|
MP:0006429
|
abnormal hyaline cartilage morphology
|
|
2.123E-6
|
1.986E-4
|
1.733E-3
|
7.347E-3
|
6
|
24
|
38
|
MP:0002191
|
abnormal artery morphology
|
|
2.217E-6
|
2.019E-4
|
1.762E-3
|
7.672E-3
|
24
|
494
|
39
|
MP:0011655
|
abnormal systemic artery morphology
|
|
2.359E-6
|
2.094E-4
|
1.827E-3
|
8.166E-3
|
17
|
268
|
40
|
MP:0003098
|
decreased tendon stiffness
|
|
2.565E-6
|
2.217E-4
|
1.935E-3
|
8.878E-3
|
4
|
7
|
41
|
MP:0013545
|
cleft hard palate
|
|
2.651E-6
|
2.217E-4
|
1.935E-3
|
9.176E-3
|
10
|
91
|
42
|
MP:0000547
|
short limbs
|
|
2.751E-6
|
2.217E-4
|
1.935E-3
|
9.521E-3
|
12
|
136
|
43
|
MP:0003560
|
osteoarthritis
|
|
2.754E-6
|
2.217E-4
|
1.935E-3
|
9.533E-3
|
6
|
25
|
44
|
MP:0000088
|
short mandible
|
|
2.932E-6
|
2.306E-4
|
2.013E-3
|
1.015E-2
|
10
|
92
|
45
|
MP:0000063
|
decreased bone mineral density
|
|
3.758E-6
|
2.890E-4
|
2.522E-3
|
1.301E-2
|
18
|
308
|
46
|
MP:0000552
|
abnormal radius morphology
|
|
3.936E-6
|
2.961E-4
|
2.584E-3
|
1.362E-2
|
10
|
95
|
47
|
MP:0009655
|
abnormal secondary palate development
|
|
4.255E-6
|
3.121E-4
|
2.724E-3
|
1.473E-2
|
11
|
118
|
48
|
MP:0004592
|
small mandible
|
|
4.328E-6
|
3.121E-4
|
2.724E-3
|
1.498E-2
|
12
|
142
|
49
|
MP:0002706
|
abnormal kidney size
|
|
4.542E-6
|
3.208E-4
|
2.800E-3
|
1.572E-2
|
19
|
344
|
50
|
MP:0003097
|
abnormal tendon stiffness
|
|
5.063E-6
|
3.505E-4
|
3.059E-3
|
1.752E-2
|
4
|
8
|
Show 45 more annotations
|
6: Domain [Display Chart]
1318 annotations before applied cutoff / 18735 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
PS01186
|
EGF 2
|
PROSITE
|
4.124E-10
|
3.254E-7
|
2.525E-6
|
5.435E-7
|
18
|
266
|
2
|
SM00181
|
EGF
|
SMART
|
4.938E-10
|
3.254E-7
|
2.525E-6
|
6.508E-7
|
17
|
236
|
3
|
IPR009030
|
Growth fac rcpt
|
InterPro
|
1.023E-9
|
3.946E-7
|
3.062E-6
|
1.349E-6
|
14
|
156
|
4
|
IPR000742
|
EGF-like dom
|
InterPro
|
1.197E-9
|
3.946E-7
|
3.062E-6
|
1.578E-6
|
17
|
250
|
5
|
IPR013032
|
EGF-like CS
|
InterPro
|
2.445E-9
|
6.444E-7
|
5.002E-6
|
3.222E-6
|
17
|
262
|
6
|
PS00022
|
EGF 1
|
PROSITE
|
1.251E-8
|
2.748E-6
|
2.133E-5
|
1.649E-5
|
16
|
256
|
7
|
IPR008160
|
Collagen
|
InterPro
|
1.977E-8
|
3.247E-6
|
2.520E-5
|
2.606E-5
|
10
|
85
|
8
|
PF01391
|
Collagen
|
Pfam
|
1.977E-8
|
3.247E-6
|
2.520E-5
|
2.606E-5
|
10
|
85
|
9
|
PF07645
|
EGF CA
|
Pfam
|
2.217E-8
|
3.247E-6
|
2.520E-5
|
2.922E-5
|
10
|
86
|
10
|
PD002078
|
Fib collagen C
|
ProDom
|
5.228E-8
|
4.922E-6
|
3.820E-5
|
6.890E-5
|
5
|
11
|
11
|
PS51461
|
NC1 FIB
|
PROSITE
|
5.228E-8
|
4.922E-6
|
3.820E-5
|
6.890E-5
|
5
|
11
|
12
|
IPR000885
|
Fib collagen C
|
InterPro
|
5.228E-8
|
4.922E-6
|
3.820E-5
|
6.890E-5
|
5
|
11
|
13
|
PF01410
|
COLFI
|
Pfam
|
5.228E-8
|
4.922E-6
|
3.820E-5
|
6.890E-5
|
5
|
11
|
14
|
SM00038
|
COLFI
|
SMART
|
5.228E-8
|
4.922E-6
|
3.820E-5
|
6.890E-5
|
5
|
11
|
15
|
SM00179
|
EGF CA
|
SMART
|
6.335E-8
|
5.567E-6
|
4.321E-5
|
8.350E-5
|
11
|
122
|
16
|
IPR001881
|
EGF-like Ca-bd dom
|
InterPro
|
7.498E-8
|
6.176E-6
|
4.794E-5
|
9.882E-5
|
11
|
124
|
17
|
PF00008
|
EGF
|
Pfam
|
8.845E-8
|
6.858E-6
|
5.323E-5
|
1.166E-4
|
11
|
126
|
18
|
PS00010
|
ASX HYDROXYL
|
PROSITE
|
9.548E-8
|
6.992E-6
|
5.426E-5
|
1.258E-4
|
10
|
100
|
19
|
IPR000152
|
EGF-type Asp/Asn hydroxyl site
|
InterPro
|
1.664E-7
|
1.154E-5
|
8.960E-5
|
2.193E-4
|
10
|
106
|
20
|
IPR018097
|
EGF Ca-bd CS
|
InterPro
|
8.074E-7
|
5.320E-5
|
4.129E-4
|
1.064E-3
|
9
|
97
|
21
|
PS01187
|
EGF CA
|
PROSITE
|
9.605E-7
|
6.028E-5
|
4.679E-4
|
1.266E-3
|
9
|
99
|
22
|
PS50026
|
EGF 3
|
PROSITE
|
1.272E-6
|
7.622E-5
|
5.916E-4
|
1.677E-3
|
13
|
236
|
23
|
PF12662
|
cEGF
|
Pfam
|
6.551E-6
|
3.598E-4
|
2.792E-3
|
8.635E-3
|
5
|
26
|
24
|
IPR026823
|
cEGF
|
InterPro
|
6.551E-6
|
3.598E-4
|
2.792E-3
|
8.635E-3
|
5
|
26
|
25
|
IPR009168
|
IGFBP1-6
|
InterPro
|
2.204E-5
|
1.024E-3
|
7.944E-3
|
2.904E-2
|
3
|
6
|
26
|
IPR022321
|
IGFBP 1-6 chordata
|
InterPro
|
2.204E-5
|
1.024E-3
|
7.944E-3
|
2.904E-2
|
3
|
6
|
27
|
IPR000716
|
Thyroglobulin 1
|
InterPro
|
2.485E-5
|
1.024E-3
|
7.944E-3
|
3.275E-2
|
4
|
17
|
28
|
SM00211
|
TY
|
SMART
|
2.485E-5
|
1.024E-3
|
7.944E-3
|
3.275E-2
|
4
|
17
|
29
|
PF00086
|
Thyroglobulin 1
|
Pfam
|
2.485E-5
|
1.024E-3
|
7.944E-3
|
3.275E-2
|
4
|
17
|
30
|
4.10.800.10
|
-
|
Gene3D
|
2.485E-5
|
1.024E-3
|
7.944E-3
|
3.275E-2
|
4
|
17
|
31
|
PS00484
|
THYROGLOBULIN 1 1
|
PROSITE
|
2.485E-5
|
1.024E-3
|
7.944E-3
|
3.275E-2
|
4
|
17
|
32
|
PS51162
|
THYROGLOBULIN 1 2
|
PROSITE
|
2.485E-5
|
1.024E-3
|
7.944E-3
|
3.275E-2
|
4
|
17
|
33
|
SM00121
|
IB
|
SMART
|
3.169E-5
|
1.266E-3
|
9.824E-3
|
4.177E-2
|
4
|
18
|
34
|
PS01208
|
VWFC 1
|
PROSITE
|
3.449E-5
|
1.337E-3
|
1.038E-2
|
4.546E-2
|
5
|
36
|
35
|
PS50184
|
VWFC 2
|
PROSITE
|
4.515E-5
|
1.700E-3
|
1.320E-2
|
5.951E-2
|
5
|
38
|
36
|
PF00219
|
IGFBP
|
Pfam
|
4.936E-5
|
1.712E-3
|
1.329E-2
|
6.506E-2
|
4
|
20
|
37
|
PS51323
|
IGFBP N 2
|
PROSITE
|
4.936E-5
|
1.712E-3
|
1.329E-2
|
6.506E-2
|
4
|
20
|
38
|
IPR000867
|
IGFBP-like
|
InterPro
|
4.936E-5
|
1.712E-3
|
1.329E-2
|
6.506E-2
|
4
|
20
|
39
|
IPR001007
|
VWF dom
|
InterPro
|
7.397E-5
|
2.500E-3
|
1.940E-2
|
9.749E-2
|
5
|
42
|
40
|
IPR020092
|
PTN MK heparin-bd GF CS
|
InterPro
|
1.089E-4
|
2.760E-3
|
2.142E-2
|
1.435E-1
|
2
|
2
|
41
|
2.30.90.10
|
-
|
Gene3D
|
1.089E-4
|
2.760E-3
|
2.142E-2
|
1.435E-1
|
2
|
2
|
42
|
IPR020091
|
PTN/MK diS
|
InterPro
|
1.089E-4
|
2.760E-3
|
2.142E-2
|
1.435E-1
|
2
|
2
|
43
|
SM00193
|
PTN
|
SMART
|
1.089E-4
|
2.760E-3
|
2.142E-2
|
1.435E-1
|
2
|
2
|
44
|
IPR020090
|
PTN/MK C dom
|
InterPro
|
1.089E-4
|
2.760E-3
|
2.142E-2
|
1.435E-1
|
2
|
2
|
45
|
PS00619
|
PTN MK 1
|
PROSITE
|
1.089E-4
|
2.760E-3
|
2.142E-2
|
1.435E-1
|
2
|
2
|
46
|
IPR000762
|
Midkine heparin-bd GF
|
InterPro
|
1.089E-4
|
2.760E-3
|
2.142E-2
|
1.435E-1
|
2
|
2
|
47
|
PS00620
|
PTN MK 2
|
PROSITE
|
1.089E-4
|
2.760E-3
|
2.142E-2
|
1.435E-1
|
2
|
2
|
48
|
PF05196
|
PTN MK N
|
Pfam
|
1.089E-4
|
2.760E-3
|
2.142E-2
|
1.435E-1
|
2
|
2
|
49
|
2.20.60.10
|
-
|
Gene3D
|
1.089E-4
|
2.760E-3
|
2.142E-2
|
1.435E-1
|
2
|
2
|
50
|
IPR020089
|
PTN/MK N dom
|
InterPro
|
1.089E-4
|
2.760E-3
|
2.142E-2
|
1.435E-1
|
2
|
2
|
Show 45 more annotations
|
7: Pathway [Display Chart]
915 annotations before applied cutoff / 10916 genes in category
|
8: Pubmed [Display Chart]
35868 annotations before applied cutoff / 51853 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
20551380
|
Proteomics characterization of extracellular space components in the human aorta.
|
Pubmed
|
1.608E-34
|
5.769E-30
|
6.383E-29
|
5.769E-30
|
23
|
101
|
2
|
19453261:gr
|
High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men.
|
GeneRIF
|
1.173E-24
|
1.403E-20
|
1.552E-19
|
4.208E-20
|
26
|
383
|
3
|
19453261
|
High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men.
|
Pubmed
|
1.173E-24
|
1.403E-20
|
1.552E-19
|
4.208E-20
|
26
|
383
|
4
|
22261194
|
Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.
|
Pubmed
|
4.220E-23
|
3.785E-19
|
4.187E-18
|
1.514E-18
|
15
|
64
|
5
|
16335952
|
Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.
|
Pubmed
|
5.315E-15
|
3.813E-11
|
4.219E-10
|
1.907E-10
|
16
|
257
|
6
|
20634891:gr
|
Maternal genes and facial clefts in offspring: a comprehensive search for genetic associations in two population-based cleft studies from Scandinavia.
|
GeneRIF
|
1.737E-14
|
8.902E-11
|
9.850E-10
|
6.231E-10
|
17
|
331
|
7
|
20634891
|
Maternal genes and facial clefts in offspring: a comprehensive search for genetic associations in two population-based cleft studies from Scandinavia.
|
Pubmed
|
1.737E-14
|
8.902E-11
|
9.850E-10
|
6.231E-10
|
17
|
331
|
8
|
23658023
|
Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.
|
Pubmed
|
2.642E-13
|
1.185E-9
|
1.311E-8
|
9.477E-9
|
10
|
73
|
9
|
20673868:gr
|
A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM).
|
GeneRIF
|
4.942E-13
|
1.582E-9
|
1.750E-8
|
1.773E-8
|
13
|
187
|
10
|
20673868
|
A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM).
|
Pubmed
|
4.942E-13
|
1.582E-9
|
1.750E-8
|
1.773E-8
|
13
|
187
|
11
|
20452482
|
Identification of fetal and maternal single nucleotide polymorphisms in candidate genes that predispose to spontaneous preterm labor with intact membranes.
|
Pubmed
|
5.292E-13
|
1.582E-9
|
1.750E-8
|
1.898E-8
|
13
|
188
|
12
|
20452482:gr
|
Identification of fetal and maternal single nucleotide polymorphisms in candidate genes that predispose to spontaneous preterm labor with intact membranes.
|
GeneRIF
|
5.292E-13
|
1.582E-9
|
1.750E-8
|
1.898E-8
|
13
|
188
|
13
|
19578796:gr
|
Association of genetic variants with chronic kidney disease in individuals with different lipid profiles.
|
GeneRIF
|
8.754E-13
|
2.243E-9
|
2.482E-8
|
3.140E-8
|
12
|
152
|
14
|
19578796
|
Association of genetic variants with chronic kidney disease in individuals with different lipid profiles.
|
Pubmed
|
8.754E-13
|
2.243E-9
|
2.482E-8
|
3.140E-8
|
12
|
152
|
15
|
23979707
|
SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers.
|
Pubmed
|
4.049E-12
|
9.681E-9
|
1.071E-7
|
1.452E-7
|
11
|
131
|
16
|
21362503
|
Protein profile of exosomes from trabecular meshwork cells.
|
Pubmed
|
1.546E-11
|
3.466E-8
|
3.835E-7
|
5.546E-7
|
8
|
49
|
17
|
20140262
|
Maternal and fetal genetic associations of PTGER3 and PON1 with preterm birth.
|
Pubmed
|
2.349E-11
|
4.680E-8
|
5.178E-7
|
8.424E-7
|
9
|
79
|
18
|
20140262:gr
|
Maternal and fetal genetic associations of PTGER3 and PON1 with preterm birth.
|
GeneRIF
|
2.349E-11
|
4.680E-8
|
5.178E-7
|
8.424E-7
|
9
|
79
|
19
|
23154389
|
Regulation of endodermal differentiation of human embryonic stem cells through integrin-ECM interactions.
|
Pubmed
|
3.303E-11
|
6.235E-8
|
6.899E-7
|
1.185E-6
|
7
|
32
|
20
|
11311202
|
Amplification of extracellular matrix and oncogenes in tat-transfected human salivary gland cell lines with expression of laminin, fibronectin, collagens I, III, IV, c-myc and p53.
|
Pubmed
|
5.133E-11
|
9.206E-8
|
1.019E-6
|
1.841E-6
|
6
|
18
|
21
|
20628624:gr
|
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".
|
GeneRIF
|
7.849E-11
|
1.036E-7
|
1.146E-6
|
2.815E-6
|
11
|
172
|
22
|
20628624
|
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".
|
Pubmed
|
7.849E-11
|
1.036E-7
|
1.146E-6
|
2.815E-6
|
11
|
172
|
23
|
19527514:gr
|
Racial disparity in pathophysiologic pathways of preterm birth based on genetic variants.
|
GeneRIF
|
8.046E-11
|
1.036E-7
|
1.146E-6
|
2.886E-6
|
10
|
128
|
24
|
18818748:gr
|
Preterm birth in Caucasians is associated with coagulation and inflammation pathway gene variants.
|
GeneRIF
|
8.046E-11
|
1.036E-7
|
1.146E-6
|
2.886E-6
|
10
|
128
|
25
|
18818748
|
Preterm birth in Caucasians is associated with coagulation and inflammation pathway gene variants.
|
Pubmed
|
8.046E-11
|
1.036E-7
|
1.146E-6
|
2.886E-6
|
10
|
128
|
26
|
19527514
|
Racial disparity in pathophysiologic pathways of preterm birth based on genetic variants.
|
Pubmed
|
8.046E-11
|
1.036E-7
|
1.146E-6
|
2.886E-6
|
10
|
128
|
27
|
20587546
|
Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection.
|
Pubmed
|
8.087E-11
|
1.036E-7
|
1.146E-6
|
2.900E-6
|
7
|
36
|
28
|
20587546:gr
|
Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection.
|
GeneRIF
|
8.087E-11
|
1.036E-7
|
1.146E-6
|
2.900E-6
|
7
|
36
|
29
|
19948975:gr
|
Integrative predictive model of coronary artery calcification in atherosclerosis.
|
GeneRIF
|
1.080E-10
|
1.291E-7
|
1.429E-6
|
3.874E-6
|
12
|
229
|
30
|
19948975
|
Integrative predictive model of coronary artery calcification in atherosclerosis.
|
Pubmed
|
1.080E-10
|
1.291E-7
|
1.429E-6
|
3.874E-6
|
12
|
229
|
31
|
19834535
|
Sequential use of transcriptional profiling, expression quantitative trait mapping, and gene association implicates MMP20 in human kidney aging.
|
Pubmed
|
1.850E-10
|
2.074E-7
|
2.294E-6
|
6.635E-6
|
9
|
99
|
32
|
19834535:gr
|
Sequential use of transcriptional profiling, expression quantitative trait mapping, and gene association implicates MMP20 in human kidney aging.
|
GeneRIF
|
1.850E-10
|
2.074E-7
|
2.294E-6
|
6.635E-6
|
9
|
99
|
33
|
11973338:gr
|
The epithelial mitogen keratinocyte growth factor binds to collagens via the consensus sequence glycine-proline-hydroxyproline.
|
GeneRIF
|
2.062E-10
|
2.242E-7
|
2.480E-6
|
7.397E-6
|
4
|
4
|
34
|
2745554
|
SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix.
|
Pubmed
|
3.499E-10
|
3.692E-7
|
4.085E-6
|
1.255E-5
|
5
|
11
|
35
|
17170699
|
ERp57 is essential for efficient folding of glycoproteins sharing common structural domains.
|
Pubmed
|
4.789E-10
|
4.908E-7
|
5.431E-6
|
1.718E-5
|
6
|
25
|
36
|
20485444:gr
|
Common polymorphisms in ITGA2, PON1 and THBS2 are associated with coronary atherosclerosis in a candidate gene association study of the Chinese Han population.
|
GeneRIF
|
7.131E-10
|
6.913E-7
|
7.649E-6
|
2.558E-5
|
9
|
115
|
37
|
20485444
|
Common polymorphisms in ITGA2, PON1 and THBS2 are associated with coronary atherosclerosis in a candidate gene association study of the Chinese Han population.
|
Pubmed
|
7.131E-10
|
6.913E-7
|
7.649E-6
|
2.558E-5
|
9
|
115
|
38
|
11973338
|
The epithelial mitogen keratinocyte growth factor binds to collagens via the consensus sequence glycine-proline-hydroxyproline.
|
Pubmed
|
1.028E-9
|
9.704E-7
|
1.074E-5
|
3.688E-5
|
4
|
5
|
39
|
19019335:gr
|
Spontaneous preterm birth in African Americans is associated with infection and inflammatory response gene variants.
|
GeneRIF
|
1.500E-9
|
1.345E-6
|
1.489E-5
|
5.382E-5
|
9
|
125
|
40
|
19019335
|
Spontaneous preterm birth in African Americans is associated with infection and inflammatory response gene variants.
|
Pubmed
|
1.500E-9
|
1.345E-6
|
1.489E-5
|
5.382E-5
|
9
|
125
|
41
|
19182256:gr
|
Exploring functional candidate genes for genetic association in german patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma.
|
GeneRIF
|
3.075E-9
|
2.626E-6
|
2.906E-5
|
1.103E-4
|
4
|
6
|
42
|
19182256
|
Exploring functional candidate genes for genetic association in german patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma.
|
Pubmed
|
3.075E-9
|
2.626E-6
|
2.906E-5
|
1.103E-4
|
4
|
6
|
43
|
24804215
|
Extracellular matrix proteins expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line.
|
Pubmed
|
3.257E-9
|
2.717E-6
|
3.007E-5
|
1.168E-4
|
5
|
16
|
44
|
20385819
|
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration.
|
Pubmed
|
6.350E-9
|
5.061E-6
|
5.600E-5
|
2.278E-4
|
5
|
18
|
45
|
8900172
|
Type I, II, III, IV, V, and VI collagens serve as extracellular ligands for the isoforms of platelet-derived growth factor (AA, BB, and AB).
|
Pubmed
|
6.350E-9
|
5.061E-6
|
5.600E-5
|
2.278E-4
|
5
|
18
|
46
|
19692168
|
Genetic susceptibility to distinct bladder cancer subphenotypes.
|
Pubmed
|
1.134E-8
|
8.653E-6
|
9.575E-5
|
4.067E-4
|
13
|
422
|
47
|
19692168:gr
|
Genetic susceptibility to distinct bladder cancer subphenotypes.
|
GeneRIF
|
1.134E-8
|
8.653E-6
|
9.575E-5
|
4.067E-4
|
13
|
422
|
48
|
16289162
|
The identification of myocilin-associated proteins in the human trabecular meshwork.
|
Pubmed
|
1.344E-8
|
1.004E-5
|
1.111E-4
|
4.821E-4
|
6
|
42
|
49
|
14760718
|
Screening for N-glycosylated proteins by liquid chromatography mass spectrometry.
|
Pubmed
|
2.708E-8
|
1.982E-5
|
2.193E-4
|
9.712E-4
|
6
|
47
|
50
|
19625176
|
PTEN identified as important risk factor of chronic obstructive pulmonary disease.
|
Pubmed
|
2.860E-8
|
2.011E-5
|
2.226E-4
|
1.026E-3
|
12
|
376
|
Show 45 more annotations
|
9: Interaction [Display Chart]
3420 annotations before applied cutoff / 16534 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
int:PDGFA
|
PDGFA interactions
|
|
2.628E-12
|
8.989E-9
|
7.834E-8
|
8.989E-9
|
8
|
16
|
2
|
int:MMP2
|
MMP2 interactions
|
|
1.220E-11
|
2.086E-8
|
1.818E-7
|
4.173E-8
|
10
|
39
|
3
|
int:COL1A1
|
COL1A1 interactions
|
|
3.902E-11
|
4.448E-8
|
3.877E-7
|
1.335E-7
|
11
|
58
|
4
|
int:PDGFB
|
PDGFB interactions
|
|
6.165E-11
|
5.226E-8
|
4.554E-7
|
2.108E-7
|
8
|
22
|
5
|
int:TGFB1
|
TGFB1 interactions
|
|
7.640E-11
|
5.226E-8
|
4.554E-7
|
2.613E-7
|
12
|
79
|
6
|
int:SPARC
|
SPARC interactions
|
|
2.026E-10
|
1.155E-7
|
1.006E-6
|
6.928E-7
|
8
|
25
|
7
|
int:THBS1
|
THBS1 interactions
|
|
3.314E-9
|
1.619E-6
|
1.411E-5
|
1.133E-5
|
9
|
49
|
8
|
int:DCN
|
DCN interactions
|
|
1.290E-7
|
5.516E-5
|
4.807E-4
|
4.413E-4
|
7
|
36
|
9
|
int:LGALS3
|
LGALS3 interactions
|
|
5.689E-7
|
2.162E-4
|
1.884E-3
|
1.946E-3
|
12
|
172
|
10
|
int:ACAN
|
ACAN interactions
|
|
1.299E-6
|
4.442E-4
|
3.871E-3
|
4.442E-3
|
5
|
18
|
11
|
int:LGALS9
|
LGALS9 interactions
|
|
1.589E-6
|
4.940E-4
|
4.305E-3
|
5.434E-3
|
8
|
73
|
12
|
int:TGFB2
|
TGFB2 interactions
|
|
1.747E-6
|
4.978E-4
|
4.339E-3
|
5.974E-3
|
5
|
19
|
13
|
int:COL3A1
|
COL3A1 interactions
|
|
3.002E-6
|
7.896E-4
|
6.881E-3
|
1.027E-2
|
5
|
21
|
14
|
int:COL2A1
|
COL2A1 interactions
|
|
3.827E-6
|
8.238E-4
|
7.179E-3
|
1.309E-2
|
6
|
38
|
15
|
int:COL1A2
|
COL1A2 interactions
|
|
3.827E-6
|
8.238E-4
|
7.179E-3
|
1.309E-2
|
6
|
38
|
16
|
int:ITGB1
|
ITGB1 interactions
|
|
3.854E-6
|
8.238E-4
|
7.179E-3
|
1.318E-2
|
9
|
109
|
17
|
int:ELN
|
ELN interactions
|
|
6.100E-6
|
1.227E-3
|
1.069E-2
|
2.086E-2
|
5
|
24
|
18
|
int:VCAN
|
VCAN interactions
|
|
9.270E-6
|
1.761E-3
|
1.535E-2
|
3.170E-2
|
5
|
26
|
19
|
int:MYOC
|
MYOC interactions
|
|
1.205E-5
|
2.169E-3
|
1.890E-2
|
4.121E-2
|
6
|
46
|
20
|
int:FGF7
|
FGF7 interactions
|
|
1.921E-5
|
3.010E-3
|
2.623E-2
|
6.570E-2
|
4
|
15
|
21
|
int:FBN1
|
FBN1 interactions
|
|
1.921E-5
|
3.010E-3
|
2.623E-2
|
6.570E-2
|
4
|
15
|
22
|
int:IGFBP3
|
IGFBP3 interactions
|
|
1.936E-5
|
3.010E-3
|
2.623E-2
|
6.622E-2
|
5
|
30
|
23
|
int:SMAD7
|
SMAD7 interactions
|
|
2.263E-5
|
3.366E-3
|
2.933E-2
|
7.741E-2
|
8
|
104
|
24
|
int:IGF1
|
IGF1 interactions
|
|
3.291E-5
|
4.690E-3
|
4.087E-2
|
1.126E-1
|
4
|
17
|
25
|
int:MMP9
|
MMP9 interactions
|
|
3.645E-5
|
4.987E-3
|
4.346E-2
|
1.247E-1
|
5
|
34
|
26
|
int:LTBP1
|
LTBP1 interactions
|
|
4.194E-5
|
5.517E-3
|
4.808E-2
|
1.434E-1
|
4
|
18
|
27
|
int:COL6A1
|
COL6A1 interactions
|
|
5.266E-5
|
6.670E-3
|
5.813E-2
|
1.801E-1
|
4
|
19
|
28
|
int:MAG
|
MAG interactions
|
|
6.525E-5
|
7.695E-3
|
6.706E-2
|
2.231E-1
|
4
|
20
|
29
|
int:BGN
|
BGN interactions
|
|
6.525E-5
|
7.695E-3
|
6.706E-2
|
2.231E-1
|
4
|
20
|
30
|
int:SMAD3
|
SMAD3 interactions
|
|
8.326E-5
|
9.492E-3
|
8.272E-2
|
2.847E-1
|
14
|
372
|
31
|
int:PLG
|
PLG interactions
|
|
9.703E-5
|
1.070E-2
|
9.329E-2
|
3.318E-1
|
6
|
66
|
32
|
int:HAPLN1
|
HAPLN1 interactions
|
|
1.120E-4
|
1.164E-2
|
1.014E-1
|
3.829E-1
|
3
|
9
|
33
|
int:NID2
|
NID2 interactions
|
|
1.161E-4
|
1.164E-2
|
1.014E-1
|
3.972E-1
|
4
|
23
|
34
|
int:COL5A1
|
COL5A1 interactions
|
|
1.161E-4
|
1.164E-2
|
1.014E-1
|
3.972E-1
|
4
|
23
|
35
|
int:CD44
|
CD44 interactions
|
|
1.245E-4
|
1.164E-2
|
1.014E-1
|
4.258E-1
|
6
|
69
|
36
|
int:CCDC80
|
CCDC80 interactions
|
|
1.259E-4
|
1.164E-2
|
1.014E-1
|
4.305E-1
|
2
|
2
|
37
|
int:ANPEP
|
ANPEP interactions
|
|
1.259E-4
|
1.164E-2
|
1.014E-1
|
4.305E-1
|
2
|
2
|
38
|
int:TGM2
|
TGM2 interactions
|
|
1.438E-4
|
1.294E-2
|
1.128E-1
|
4.916E-1
|
7
|
101
|
39
|
int:ANTXR2
|
ANTXR2 interactions
|
|
1.586E-4
|
1.391E-2
|
1.212E-1
|
5.424E-1
|
3
|
10
|
40
|
int:SGTA
|
SGTA interactions
|
|
1.772E-4
|
1.515E-2
|
1.320E-1
|
6.060E-1
|
8
|
139
|
41
|
int:CXCL12
|
CXCL12 interactions
|
|
2.163E-4
|
1.761E-2
|
1.535E-1
|
7.397E-1
|
3
|
11
|
42
|
int:TGFBI
|
TGFBI interactions
|
|
2.163E-4
|
1.761E-2
|
1.535E-1
|
7.397E-1
|
3
|
11
|
43
|
int:MMP3
|
MMP3 interactions
|
|
2.222E-4
|
1.768E-2
|
1.540E-1
|
7.601E-1
|
4
|
27
|
44
|
int:ITGB3
|
ITGB3 interactions
|
|
2.400E-4
|
1.865E-2
|
1.626E-1
|
8.208E-1
|
5
|
50
|
45
|
int:PF4
|
PF4 interactions
|
|
2.860E-4
|
2.174E-2
|
1.894E-1
|
9.781E-1
|
3
|
12
|
46
|
int:COL5A3
|
COL5A3 interactions
|
|
3.748E-4
|
2.671E-2
|
2.327E-1
|
1.000E0
|
2
|
3
|
47
|
int:MMP25
|
MMP25 interactions
|
|
3.748E-4
|
2.671E-2
|
2.327E-1
|
1.000E0
|
2
|
3
|
48
|
int:COL6A3
|
COL6A3 interactions
|
|
3.748E-4
|
2.671E-2
|
2.327E-1
|
1.000E0
|
2
|
3
|
49
|
int:ADAM12
|
ADAM12 interactions
|
|
4.654E-4
|
3.248E-2
|
2.831E-1
|
1.000E0
|
3
|
14
|
50
|
int:SOX10
|
SOX10 interactions
|
|
4.916E-4
|
3.363E-2
|
2.930E-1
|
1.000E0
|
4
|
33
|
Show 45 more annotations
|
10: Cytoband [Display Chart]
176 annotations before applied cutoff / 34661 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
7q22
|
7q22
|
|
6.848E-5
|
1.205E-2
|
6.931E-2
|
1.205E-2
|
4
|
39
|
|
11: Transcription Factor Binding Site [Display Chart]
515 annotations before applied cutoff / 9770 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
GTGGGTGK UNKNOWN
|
GTGGGTGK UNKNOWN
|
|
1.288E-7
|
6.635E-5
|
4.527E-4
|
6.635E-5
|
16
|
234
|
2
|
V$OCT1 05
|
V$OCT1 05
|
|
3.711E-5
|
9.525E-3
|
6.498E-2
|
1.911E-2
|
12
|
213
|
3
|
V$MEF2 01
|
V$MEF2 01
|
|
5.548E-5
|
9.525E-3
|
6.498E-2
|
2.857E-2
|
9
|
125
|
4
|
AAANWWTGC UNKNOWN
|
AAANWWTGC UNKNOWN
|
|
1.072E-4
|
1.380E-2
|
9.417E-2
|
5.521E-2
|
10
|
168
|
5
|
WGGAATGY V$TEF1 Q6
|
WGGAATGY V$TEF1 Q6
|
|
2.449E-4
|
2.214E-2
|
1.511E-1
|
1.261E-1
|
13
|
299
|
6
|
V$RP58 01
|
V$RP58 01
|
|
2.579E-4
|
2.214E-2
|
1.511E-1
|
1.328E-1
|
10
|
187
|
7
|
V$POU6F1 01
|
V$POU6F1 01
|
|
3.464E-4
|
2.549E-2
|
1.739E-1
|
1.784E-1
|
10
|
194
|
8
|
V$SMAD4 Q6
|
V$SMAD4 Q6
|
|
4.412E-4
|
2.840E-2
|
1.938E-1
|
2.272E-1
|
10
|
200
|
9
|
V$NKX25 02
|
V$NKX25 02
|
|
5.566E-4
|
2.867E-2
|
1.956E-1
|
2.867E-1
|
10
|
206
|
10
|
V$AFP1 Q6
|
V$AFP1 Q6
|
|
5.566E-4
|
2.867E-2
|
1.956E-1
|
2.867E-1
|
10
|
206
|
11
|
V$AMEF2 Q6
|
V$AMEF2 Q6
|
|
6.710E-4
|
3.142E-2
|
2.143E-1
|
3.456E-1
|
10
|
211
|
12
|
V$HP1SITEFACTOR Q6
|
V$HP1SITEFACTOR Q6
|
|
1.207E-3
|
4.962E-2
|
3.386E-1
|
6.215E-1
|
9
|
189
|
13
|
V$HMEF2 Q6
|
V$HMEF2 Q6
|
|
1.340E-3
|
4.962E-2
|
3.386E-1
|
6.900E-1
|
7
|
120
|
14
|
WGTTNNNNNAAA UNKNOWN
|
WGTTNNNNNAAA UNKNOWN
|
|
1.349E-3
|
4.962E-2
|
3.386E-1
|
6.947E-1
|
15
|
450
|
Show 9 more annotations
|
12: Gene Family [Display Chart]
109 annotations before applied cutoff / 18194 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
490
|
Collagens
|
genenames.org
|
5.183E-8
|
5.649E-6
|
2.979E-5
|
5.649E-6
|
7
|
46
|
2
|
1065
|
Insulin like growth factor binding proteins
|
genenames.org
|
8.398E-6
|
4.577E-4
|
2.414E-3
|
9.154E-4
|
3
|
6
|
3
|
626
|
Laminin subunits
|
genenames.org
|
8.934E-5
|
2.435E-3
|
1.284E-2
|
9.738E-3
|
3
|
12
|
4
|
573
|
Small leucine rich repeat proteoglycans
|
genenames.org
|
8.934E-5
|
2.435E-3
|
1.284E-2
|
9.738E-3
|
3
|
12
|
5
|
628
|
Latent transforming growth factor beta binding proteins
|
genenames.org
|
3.393E-4
|
7.397E-3
|
3.900E-2
|
3.698E-2
|
2
|
4
|
6
|
1179
|
Complement system|Sushi domain containing
|
genenames.org
|
9.166E-4
|
1.665E-2
|
8.781E-2
|
9.991E-2
|
4
|
57
|
7
|
556
|
Fibulins
|
genenames.org
|
1.552E-3
|
1.804E-2
|
9.511E-2
|
1.692E-1
|
2
|
8
|
8
|
950
|
Gelsolin/villins
|
genenames.org
|
1.552E-3
|
1.804E-2
|
9.511E-2
|
1.692E-1
|
2
|
8
|
9
|
1278
|
SPARC family
|
genenames.org
|
1.552E-3
|
1.804E-2
|
9.511E-2
|
1.692E-1
|
2
|
8
|
10
|
1159
|
CD molecules|Integrin beta subunits
|
genenames.org
|
1.986E-3
|
1.804E-2
|
9.511E-2
|
2.164E-1
|
2
|
9
|
11
|
1234
|
Complement system|Endogenous ligands|C3 and PZP like, alpha-2-macroglobulin domain containing
|
genenames.org
|
1.986E-3
|
1.804E-2
|
9.511E-2
|
2.164E-1
|
2
|
9
|
12
|
436
|
Glycosyltransferase family 8
|
genenames.org
|
1.986E-3
|
1.804E-2
|
9.511E-2
|
2.164E-1
|
2
|
9
|
13
|
492
|
Complement system
|
genenames.org
|
2.538E-3
|
2.075E-2
|
1.094E-1
|
2.767E-1
|
3
|
36
|
14
|
743
|
Short chain dehydrogenase/reductase superfamily
|
genenames.org
|
2.665E-3
|
2.075E-2
|
1.094E-1
|
2.905E-1
|
4
|
76
|
15
|
1250
|
Gla domain containing
|
genenames.org
|
4.218E-3
|
3.065E-2
|
1.616E-1
|
4.597E-1
|
2
|
13
|
Show 10 more annotations
|
13: Coexpression [Display Chart]
6646 annotations before applied cutoff / 21867 genes in category
|
14: Coexpression Atlas [Display Chart]
3457 annotations before applied cutoff / 20974 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
GSM777043 500
|
Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3
|
Immgen.org, GSE15907
|
3.621E-74
|
1.252E-70
|
1.092E-69
|
1.252E-70
|
75
|
445
|
2
|
GSM777046 500
|
Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4
|
Immgen.org, GSE15907
|
3.486E-73
|
6.025E-70
|
5.257E-69
|
1.205E-69
|
74
|
438
|
3
|
GSM777050 500
|
Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5
|
Immgen.org, GSE15907
|
1.099E-63
|
1.267E-60
|
1.105E-59
|
3.800E-60
|
69
|
467
|
4
|
GSM777055 500
|
Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4
|
Immgen.org, GSE15907
|
4.748E-63
|
4.103E-60
|
3.580E-59
|
1.641E-59
|
68
|
455
|
5
|
GSM777067 500
|
Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2
|
Immgen.org, GSE15907
|
2.554E-60
|
1.766E-57
|
1.541E-56
|
8.830E-57
|
66
|
453
|
6
|
54Dn SubClass 54Dn 1SK Top 500 All
|
54Dn SubClass 54Dn 1SK Top 500 All
|
Brain Map - Allen iN
|
7.511E-49
|
4.328E-46
|
3.776E-45
|
2.597E-45
|
58
|
461
|
7
|
80Dn Top 500 All
|
80Dn Top 500 All
|
Brain Map - Allen iN
|
4.305E-47
|
2.126E-44
|
1.855E-43
|
1.488E-43
|
58
|
494
|
8
|
PCBC ctl CardiacMyocyte 500
|
Progenitor-Cell-Biology-Consortium reference CardiacMyocyte top-relative-expression-ranked 500
|
PCBC
|
3.128E-43
|
1.352E-40
|
1.180E-39
|
1.082E-39
|
55
|
495
|
9
|
GSM777043 100
|
Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3
|
Immgen.org, GSE15907
|
3.073E-41
|
1.180E-38
|
1.030E-37
|
1.062E-37
|
32
|
97
|
10
|
54Dn SubClass 54Dn 1SK Top 500 Cluster 2
|
54Dn SubClass 54Dn 1SK Top 500 Cluster 2
|
Brain Map - Allen iN
|
8.953E-41
|
3.095E-38
|
2.700E-37
|
3.095E-37
|
43
|
265
|
11
|
JC fibro 1000 K1
|
JC fibro top-relative-expression-ranked 1000 k-means-cluster#1
|
PCBC
|
9.800E-40
|
3.080E-37
|
2.687E-36
|
3.388E-36
|
51
|
464
|
12
|
54Dn Top 500 All
|
54Dn Top 500 All
|
Brain Map - Allen iN
|
2.093E-38
|
6.030E-36
|
5.262E-35
|
7.236E-35
|
51
|
493
|
13
|
GSM777046 100
|
Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4
|
Immgen.org, GSE15907
|
5.714E-36
|
1.519E-33
|
1.326E-32
|
1.975E-32
|
29
|
97
|
14
|
gudmap dev gonad e13.5 M InterstitTestis Sma 500
|
dev gonad e13.5 M InterstitTestis Sma top-relative-expression-ranked 500
|
Gudmap Mouse ST 1.0
|
8.033E-35
|
1.984E-32
|
1.731E-31
|
2.777E-31
|
43
|
362
|
15
|
endothelial SubClass DCN-hi Top 500 All
|
endothelial SubClass DCN-hi Top 500 All
|
Brain Map - Barres
|
9.236E-35
|
2.129E-32
|
1.857E-31
|
3.193E-31
|
48
|
495
|
16
|
PCBC ctl BronchSmoothMuscl 500
|
Progenitor-Cell-Biology-Consortium reference BronchSmoothMuscl top-relative-expression-ranked 500
|
PCBC
|
1.712E-32
|
3.698E-30
|
3.227E-29
|
5.917E-29
|
46
|
494
|
17
|
gudmap dev gonad e13.5 M InterstitFLeydig MafB k3 1000
|
dev gonad e13.5 M InterstitFLeydig MafB k-means-cluster#3 top-relative-expression-ranked 1000
|
Gudmap Mouse ST 1.0
|
2.059E-32
|
4.187E-30
|
3.654E-29
|
7.118E-29
|
40
|
336
|
18
|
gudmap dev gonad e11.5 M GonadVasMes Flk 500
|
dev gonad e11.5 M GonadVasMes Flk top-relative-expression-ranked 500
|
Gudmap Mouse ST 1.0
|
4.095E-32
|
7.864E-30
|
6.862E-29
|
1.415E-28
|
43
|
419
|
19
|
gudmap dev gonad e11.5 F GonadVasMes Flk 500
|
dev gonad e11.5 F GonadVasMes Flk top-relative-expression-ranked 500
|
Gudmap Mouse ST 1.0
|
6.754E-32
|
1.229E-29
|
1.072E-28
|
2.335E-28
|
43
|
424
|
20
|
gudmap dev gonad e12.5 M InterstitTestis Sma 500
|
dev gonad e12.5 M InterstitTestis Sma top-relative-expression-ranked 500
|
Gudmap Mouse ST 1.0
|
9.125E-32
|
1.577E-29
|
1.376E-28
|
3.155E-28
|
41
|
374
|
21
|
gudmap dev gonad e13.5 F VascAssocMesenchStromOvary MafB 500
|
dev gonad e13.5 F VascAssocMesenchStromOvary MafB top-relative-expression-ranked 500
|
Gudmap Mouse ST 1.0
|
2.576E-31
|
4.241E-29
|
3.701E-28
|
8.906E-28
|
40
|
358
|
22
|
gudmap dev gonad e12.5 M InterstitLeydig MafB 500
|
dev gonad e12.5 M InterstitLeydig MafB top-relative-expression-ranked 500
|
Gudmap Mouse ST 1.0
|
4.978E-31
|
7.822E-29
|
6.825E-28
|
1.721E-27
|
40
|
364
|
23
|
gudmap dev gonad e13.5 M InterstitFLeydig MafB 500
|
dev gonad e13.5 M InterstitFLeydig MafB top-relative-expression-ranked 500
|
Gudmap Mouse ST 1.0
|
3.357E-30
|
5.045E-28
|
4.402E-27
|
1.160E-26
|
39
|
356
|
24
|
gudmap kidney adult RenalCapsule 500
|
kidney adult RenalCapsule top-relative-expression-ranked 500
|
Gudmap Mouse MOE430.2
|
3.714E-30
|
5.350E-28
|
4.668E-27
|
1.284E-26
|
41
|
410
|
25
|
GSM777050 100
|
Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5
|
Immgen.org, GSE15907
|
6.153E-29
|
8.509E-27
|
7.424E-26
|
2.127E-25
|
24
|
87
|
26
|
gudmap dev gonad e13.5 F VascAssocMesenchStromOvary MafB k2 1000
|
dev gonad e13.5 F VascAssocMesenchStromOvary MafB k-means-cluster#2 top-relative-expression-ranked 1000
|
Gudmap Mouse ST 1.0
|
1.260E-28
|
1.675E-26
|
1.462E-25
|
4.356E-25
|
34
|
266
|
27
|
JC fibro 500 K3
|
JC fibro top-relative-expression-ranked 500 k-means-cluster#3
|
PCBC
|
2.230E-28
|
2.855E-26
|
2.491E-25
|
7.708E-25
|
31
|
206
|
28
|
ratio EB vs SC 1000 K1
|
ratio EmbryoidBody vs StemCell top-relative-expression-ranked 1000 k-means-cluster#1
|
PCBC
|
2.292E-26
|
2.829E-24
|
2.469E-23
|
7.922E-23
|
35
|
336
|
29
|
GSM777063 500
|
Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4
|
Immgen.org, GSE15907
|
2.446E-26
|
2.916E-24
|
2.545E-23
|
8.457E-23
|
39
|
450
|
30
|
GSM777067 100
|
Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2
|
Immgen.org, GSE15907
|
6.445E-26
|
7.427E-24
|
6.480E-23
|
2.228E-22
|
22
|
85
|
31
|
OPC Top 500 All
|
OPC Top 500 All
|
Brain Map - Barres
|
6.908E-26
|
7.704E-24
|
6.722E-23
|
2.388E-22
|
40
|
494
|
32
|
endothelial Top 500 All
|
endothelial Top 500 All
|
Brain Map - Barres
|
8.052E-26
|
8.699E-24
|
7.590E-23
|
2.784E-22
|
40
|
496
|
33
|
GSM777055 100
|
Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4
|
Immgen.org, GSE15907
|
8.591E-26
|
8.999E-24
|
7.852E-23
|
2.970E-22
|
22
|
86
|
34
|
gudmap dev gonad e12.5 M InterstitTestis Sma k4 1000
|
dev gonad e12.5 M InterstitTestis Sma k-means-cluster#4 top-relative-expression-ranked 1000
|
Gudmap Mouse ST 1.0
|
4.717E-24
|
4.796E-22
|
4.185E-21
|
1.631E-20
|
27
|
191
|
35
|
gudmap dev gonad e13.5 F VascAssocMesenchStromOvary Sma 500
|
dev gonad e13.5 F VascAssocMesenchStromOvary Sma top-relative-expression-ranked 500
|
Gudmap Mouse ST 1.0
|
1.040E-23
|
1.012E-21
|
8.827E-21
|
3.594E-20
|
34
|
373
|
36
|
JC fibro 500
|
JC fibro top-relative-expression-ranked 500
|
PCBC
|
1.054E-23
|
1.012E-21
|
8.827E-21
|
3.642E-20
|
38
|
497
|
37
|
GSM777059 500
|
Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4
|
Immgen.org, GSE15907
|
1.674E-23
|
1.564E-21
|
1.364E-20
|
5.786E-20
|
36
|
439
|
38
|
54Dn Top 500 Cluster 1
|
54Dn Top 500 Cluster 1
|
Brain Map - Allen iN
|
3.586E-23
|
3.263E-21
|
2.847E-20
|
1.240E-19
|
25
|
164
|
39
|
Lungmap Mouse e16.5 Myofibro Top 500 All
|
Lungmap Mouse e16.5 Myofibro Top 500 All
|
Lungmap Mouse Single Cell (Lungmap.net)
|
4.315E-23
|
3.825E-21
|
3.337E-20
|
1.492E-19
|
35
|
420
|
40
|
gudmap dev gonad e11.5 M GonadVasMes Flk k1 1000
|
dev gonad e11.5 M GonadVasMes Flk k-means-cluster#1 top-relative-expression-ranked 1000
|
Gudmap Mouse ST 1.0
|
7.491E-23
|
6.428E-21
|
5.608E-20
|
2.590E-19
|
32
|
338
|
41
|
GSM777037 500
|
Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4
|
Immgen.org, GSE15907
|
7.623E-23
|
6.428E-21
|
5.608E-20
|
2.635E-19
|
36
|
459
|
42
|
gudmap dev gonad e12.5 M InterstitLeydig MafB k1 1000
|
dev gonad e12.5 M InterstitLeydig MafB k-means-cluster#1 top-relative-expression-ranked 1000
|
Gudmap Mouse ST 1.0
|
7.910E-23
|
6.510E-21
|
5.681E-20
|
2.734E-19
|
31
|
311
|
43
|
gudmap kidney adult RenalCapsule k2 1000
|
kidney adult RenalCapsule k-means-cluster#2 top-relative-expression-ranked 1000
|
Gudmap Mouse MOE430.2
|
1.090E-22
|
8.762E-21
|
7.645E-20
|
3.768E-19
|
33
|
371
|
44
|
gudmap dev gonad e11.5 M GonMes Sma 500
|
dev gonad e11.5 M GonMes Sma top-relative-expression-ranked 500
|
Gudmap Mouse ST 1.0
|
1.187E-22
|
9.323E-21
|
8.134E-20
|
4.102E-19
|
35
|
433
|
45
|
gudmap kidney adult RenalCapsule 200
|
kidney adult RenalCapsule top-relative-expression-ranked 200
|
Gudmap Mouse MOE430.2
|
2.186E-22
|
1.679E-20
|
1.465E-19
|
7.557E-19
|
25
|
176
|
46
|
gudmap dev gonad e11.5 F GonadVasMes Flk k3 1000
|
dev gonad e11.5 F GonadVasMes Flk k-means-cluster#3 top-relative-expression-ranked 1000
|
Gudmap Mouse ST 1.0
|
3.399E-22
|
2.555E-20
|
2.229E-19
|
1.175E-18
|
32
|
355
|
47
|
gudmap dev gonad e13.5 F VascAssocMesenchStromOvary MafB k3 500
|
dev gonad e13.5 F VascAssocMesenchStromOvary MafB k-means-cluster#3 top-relative-expression-ranked 500
|
Gudmap Mouse ST 1.0
|
4.298E-22
|
3.162E-20
|
2.759E-19
|
1.486E-18
|
22
|
123
|
48
|
gudmap dev gonad e12.5 F VasAssMesen MafB 500
|
dev gonad e12.5 F VasAssMesen MafB top-relative-expression-ranked 500
|
Gudmap Mouse ST 1.0
|
4.852E-22
|
3.444E-20
|
3.005E-19
|
1.677E-18
|
33
|
389
|
49
|
Lungmap Mouse e16.5 Matrix fibroblast Top 500 All
|
Mouse Lung E16.5 Matrix Fibroblast top 500
|
Lungmap Mouse Single Cell (Lungmap.net)
|
4.882E-22
|
3.444E-20
|
3.005E-19
|
1.688E-18
|
34
|
420
|
50
|
80Dn SubClass 80Dn 1 Top 500 Cluster 0
|
80Dn SubClass 80Dn 1 Top 500 Cluster 0
|
Brain Map - Allen iN
|
6.461E-22
|
4.348E-20
|
3.794E-19
|
2.233E-18
|
36
|
489
|
Show 45 more annotations
|
15: Computational [Display Chart]
372 annotations before applied cutoff / 9399 genes in category
|
16: MicroRNA [Display Chart]
1332 annotations before applied cutoff / 19844 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
hsa-miR-29c:miRecords TarBase
|
hsa-miR-29c:miRecords TarBase
|
miRecords_TarBase
|
2.603E-7
|
3.468E-4
|
2.695E-3
|
3.468E-4
|
5
|
15
|
2
|
miR-203:PicTar
|
miR-203:PicTar
|
PicTar
|
1.208E-6
|
8.047E-4
|
6.254E-3
|
1.609E-3
|
15
|
330
|
3
|
hsa-miR-421:TargetScan
|
hsa-miR-421:TargetScan
|
TargetScan
|
3.526E-6
|
1.309E-3
|
1.017E-2
|
4.696E-3
|
13
|
271
|
4
|
hsa-miR-124:miRecords TarBase
|
hsa-miR-124:miRecords TarBase
|
miRecords_TarBase
|
5.561E-6
|
1.309E-3
|
1.017E-2
|
7.408E-3
|
11
|
200
|
5
|
TGGTGCT,MIR-29A:MSigDB
|
TGGTGCT,MIR-29A:MSigDB
|
MSigDB
|
6.878E-6
|
1.309E-3
|
1.017E-2
|
9.161E-3
|
17
|
480
|
6
|
TGGTGCT,MIR-29C:MSigDB
|
TGGTGCT,MIR-29C:MSigDB
|
MSigDB
|
6.878E-6
|
1.309E-3
|
1.017E-2
|
9.161E-3
|
17
|
480
|
7
|
TGGTGCT,MIR-29B:MSigDB
|
TGGTGCT,MIR-29B:MSigDB
|
MSigDB
|
6.878E-6
|
1.309E-3
|
1.017E-2
|
9.161E-3
|
17
|
480
|
8
|
hsa-miR-29c:miRTarbase
|
hsa-miR-29c:miRTarbase
|
miRTarbase
|
1.294E-5
|
2.154E-3
|
1.674E-2
|
1.723E-2
|
5
|
31
|
9
|
miR-199a-star:PicTar
|
miR-199a-star:PicTar
|
PicTar
|
2.329E-5
|
3.447E-3
|
2.679E-2
|
3.103E-2
|
15
|
422
|
10
|
miR-144:PicTar
|
miR-144:PicTar
|
PicTar
|
3.134E-5
|
4.174E-3
|
3.244E-2
|
4.174E-2
|
15
|
433
|
11
|
hsa-miR-4286:mirSVR highEffct
|
hsa-miR-4286:mirSVR nonconserved highEffect-0.5
|
MicroRNA.org
|
4.163E-5
|
5.041E-3
|
3.918E-2
|
5.545E-2
|
14
|
392
|
12
|
hsa-miR-452:PITA
|
hsa-miR-452:PITA TOP
|
PITA
|
4.985E-5
|
5.076E-3
|
3.945E-2
|
6.640E-2
|
15
|
451
|
13
|
AAAGGGA,MIR-211:MSigDB
|
AAAGGGA,MIR-211:MSigDB
|
MSigDB
|
5.335E-5
|
5.076E-3
|
3.945E-2
|
7.106E-2
|
10
|
211
|
14
|
AAAGGGA,MIR-204:MSigDB
|
AAAGGGA,MIR-204:MSigDB
|
MSigDB
|
5.335E-5
|
5.076E-3
|
3.945E-2
|
7.106E-2
|
10
|
211
|
15
|
hsa-miR-587:PITA
|
hsa-miR-587:PITA TOP
|
PITA
|
7.673E-5
|
5.424E-3
|
4.215E-2
|
1.022E-1
|
14
|
415
|
16
|
hsa-miR-34c-5p:TargetScan
|
hsa-miR-34c-5p:TargetScan
|
TargetScan
|
7.737E-5
|
5.424E-3
|
4.215E-2
|
1.031E-1
|
15
|
469
|
17
|
hsa-miR-449b:TargetScan
|
hsa-miR-449b:TargetScan
|
TargetScan
|
7.737E-5
|
5.424E-3
|
4.215E-2
|
1.031E-1
|
15
|
469
|
18
|
hsa-miR-34a:TargetScan
|
hsa-miR-34a:TargetScan
|
TargetScan
|
7.737E-5
|
5.424E-3
|
4.215E-2
|
1.031E-1
|
15
|
469
|
19
|
hsa-miR-449a:TargetScan
|
hsa-miR-449a:TargetScan
|
TargetScan
|
7.737E-5
|
5.424E-3
|
4.215E-2
|
1.031E-1
|
15
|
469
|
20
|
miR-34a:PicTar
|
miR-34a:PicTar
|
PicTar
|
9.008E-5
|
5.999E-3
|
4.663E-2
|
1.200E-1
|
13
|
369
|
21
|
hsa-miR-500:PITA
|
hsa-miR-500:PITA TOP
|
PITA
|
1.086E-4
|
6.756E-3
|
5.251E-2
|
1.446E-1
|
12
|
325
|
22
|
miR-101:PicTar
|
miR-101:PicTar
|
PicTar
|
1.116E-4
|
6.756E-3
|
5.251E-2
|
1.486E-1
|
14
|
430
|
23
|
hsa-miR-767-5p:PITA
|
hsa-miR-767-5p:PITA TOP
|
PITA
|
1.186E-4
|
6.871E-3
|
5.340E-2
|
1.580E-1
|
11
|
279
|
24
|
hsa-miR-448:PITA
|
hsa-miR-448:PITA TOP
|
PITA
|
1.353E-4
|
7.192E-3
|
5.589E-2
|
1.802E-1
|
14
|
438
|
25
|
ATACTGT,MIR-144:MSigDB
|
ATACTGT,MIR-144:MSigDB
|
MSigDB
|
1.429E-4
|
7.192E-3
|
5.589E-2
|
1.903E-1
|
9
|
193
|
26
|
miR-369-3p:PicTar
|
miR-369-3p:PicTar
|
PicTar
|
1.441E-4
|
7.192E-3
|
5.589E-2
|
1.920E-1
|
12
|
335
|
27
|
hsa-miR-370:TargetScan
|
hsa-miR-370:TargetScan
|
TargetScan
|
1.497E-4
|
7.192E-3
|
5.589E-2
|
1.993E-1
|
10
|
239
|
28
|
hsa-miR-132:PITA
|
hsa-miR-132:PITA TOP
|
PITA
|
1.566E-4
|
7.192E-3
|
5.589E-2
|
2.086E-1
|
12
|
338
|
29
|
hsa-miR-212:PITA
|
hsa-miR-212:PITA TOP
|
PITA
|
1.566E-4
|
7.192E-3
|
5.589E-2
|
2.086E-1
|
12
|
338
|
30
|
hsa-miR-501-5p:PITA
|
hsa-miR-501-5p:PITA TOP
|
PITA
|
1.654E-4
|
7.343E-3
|
5.707E-2
|
2.203E-1
|
12
|
340
|
31
|
miR-140:PicTar
|
miR-140:PicTar
|
PicTar
|
1.732E-4
|
7.345E-3
|
5.708E-2
|
2.307E-1
|
9
|
198
|
32
|
hsa-miR-34c-5p:PITA
|
hsa-miR-34c-5p:PITA TOP
|
PITA
|
1.930E-4
|
7.345E-3
|
5.708E-2
|
2.571E-1
|
11
|
295
|
33
|
hsa-miR-449b:PITA
|
hsa-miR-449b:PITA TOP
|
PITA
|
1.930E-4
|
7.345E-3
|
5.708E-2
|
2.571E-1
|
11
|
295
|
34
|
hsa-miR-449a:PITA
|
hsa-miR-449a:PITA TOP
|
PITA
|
1.930E-4
|
7.345E-3
|
5.708E-2
|
2.571E-1
|
11
|
295
|
35
|
hsa-miR-34a:PITA
|
hsa-miR-34a:PITA TOP
|
PITA
|
1.930E-4
|
7.345E-3
|
5.708E-2
|
2.571E-1
|
11
|
295
|
36
|
hsa-miR-645:PITA
|
hsa-miR-645:PITA TOP
|
PITA
|
2.079E-4
|
7.513E-3
|
5.839E-2
|
2.770E-1
|
6
|
85
|
37
|
miR-338:PicTar
|
miR-338:PicTar
|
PicTar
|
2.087E-4
|
7.513E-3
|
5.839E-2
|
2.780E-1
|
9
|
203
|
38
|
miR-200b:PicTar
|
miR-200b:PicTar
|
PicTar
|
2.558E-4
|
8.930E-3
|
6.940E-2
|
3.408E-1
|
14
|
466
|
39
|
miR-200c:PicTar
|
miR-200c:PicTar
|
PicTar
|
2.615E-4
|
8.930E-3
|
6.940E-2
|
3.483E-1
|
14
|
467
|
40
|
miR-212:PicTar
|
miR-212:PicTar
|
PicTar
|
2.878E-4
|
9.351E-3
|
7.267E-2
|
3.834E-1
|
9
|
212
|
41
|
miR-132:PicTar
|
miR-132:PicTar
|
PicTar
|
2.878E-4
|
9.351E-3
|
7.267E-2
|
3.834E-1
|
9
|
212
|
42
|
hsa-miR-892a:PITA
|
hsa-miR-892a:PITA TOP
|
PITA
|
3.132E-4
|
9.500E-3
|
7.384E-2
|
4.172E-1
|
10
|
262
|
43
|
CATTTCA,MIR-203:MSigDB
|
CATTTCA,MIR-203:MSigDB
|
MSigDB
|
3.327E-4
|
9.500E-3
|
7.384E-2
|
4.431E-1
|
10
|
264
|
44
|
hsa-miR-182:PITA
|
hsa-miR-182:PITA TOP
|
PITA
|
3.377E-4
|
9.500E-3
|
7.384E-2
|
4.499E-1
|
14
|
479
|
45
|
CTTTGCA,MIR-527:MSigDB
|
CTTTGCA,MIR-527:MSigDB
|
MSigDB
|
3.416E-4
|
9.500E-3
|
7.384E-2
|
4.550E-1
|
9
|
217
|
46
|
hsa-miR-597:mirSVR highEffct
|
hsa-miR-597:mirSVR nonconserved highEffect-0.5
|
MicroRNA.org
|
3.449E-4
|
9.500E-3
|
7.384E-2
|
4.594E-1
|
14
|
480
|
47
|
hsa-miR-204:miRTarbase
|
hsa-miR-204:miRTarbase
|
miRTarbase
|
3.527E-4
|
9.500E-3
|
7.384E-2
|
4.698E-1
|
4
|
34
|
48
|
TATTATA,MIR-374:MSigDB
|
TATTATA,MIR-374:MSigDB
|
MSigDB
|
3.531E-4
|
9.500E-3
|
7.384E-2
|
4.704E-1
|
10
|
266
|
49
|
CACTGCC,MIR-34A:MSigDB
|
CACTGCC,MIR-34A:MSigDB
|
MSigDB
|
3.638E-4
|
9.500E-3
|
7.384E-2
|
4.845E-1
|
10
|
267
|
50
|
CACTGCC,MIR-34C:MSigDB
|
CACTGCC,MIR-34C:MSigDB
|
MSigDB
|
3.638E-4
|
9.500E-3
|
7.384E-2
|
4.845E-1
|
10
|
267
|
Show 45 more annotations
|
17: Drug [Display Chart]
27516 annotations before applied cutoff / 22098 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
CID000024766
|
chondroitin sulfate
|
Stitch
|
5.589E-23
|
1.487E-18
|
1.606E-17
|
1.538E-18
|
34
|
413
|
2
|
D017258
|
Medroxyprogesterone Acetate
|
CTD
|
1.081E-22
|
1.487E-18
|
1.606E-17
|
2.975E-18
|
33
|
390
|
3
|
C488369
|
dasatinib
|
CTD
|
4.104E-20
|
3.214E-16
|
3.471E-15
|
1.129E-15
|
33
|
472
|
4
|
D000069439
|
Dasatinib
|
CTD
|
4.672E-20
|
3.214E-16
|
3.471E-15
|
1.285E-15
|
33
|
474
|
5
|
CID000032756
|
dermatan sulfate
|
Stitch
|
4.192E-18
|
2.307E-14
|
2.491E-13
|
1.153E-13
|
23
|
220
|
6
|
D015056
|
1-Methyl-3-isobutylxanthine
|
CTD
|
1.874E-16
|
8.592E-13
|
9.279E-12
|
5.155E-12
|
27
|
391
|
7
|
C010176
|
halofuginone
|
CTD
|
1.739E-15
|
6.837E-12
|
7.383E-11
|
4.786E-11
|
17
|
127
|
8
|
CID000024759
|
hyaluronan
|
Stitch
|
2.639E-15
|
9.075E-12
|
9.801E-11
|
7.260E-11
|
22
|
263
|
9
|
CID000104802
|
Rgd Peptide
|
Stitch
|
4.374E-15
|
1.337E-11
|
1.444E-10
|
1.204E-10
|
21
|
239
|
10
|
D003994
|
Bucladesine
|
CTD
|
5.373E-13
|
1.432E-9
|
1.546E-8
|
1.478E-8
|
21
|
305
|
11
|
D005944
|
Glucosamine
|
CTD
|
5.724E-13
|
1.432E-9
|
1.546E-8
|
1.575E-8
|
21
|
306
|
12
|
CID005288571
|
AC1NRBPT
|
Stitch
|
1.492E-12
|
3.422E-9
|
3.695E-8
|
4.106E-8
|
16
|
162
|
13
|
C487081
|
belinostat
|
CTD
|
3.988E-12
|
8.441E-9
|
9.116E-8
|
1.097E-7
|
23
|
417
|
14
|
CID000002299
|
AC1L1DD6
|
Stitch
|
6.953E-12
|
1.288E-8
|
1.391E-7
|
1.913E-7
|
16
|
179
|
15
|
D014302
|
Trinitrobenzenesulfonic Acid
|
CTD
|
7.021E-12
|
1.288E-8
|
1.391E-7
|
1.932E-7
|
22
|
388
|
16
|
C011559
|
tributyltin
|
CTD
|
9.233E-12
|
1.588E-8
|
1.715E-7
|
2.540E-7
|
20
|
316
|
17
|
CID000001071
|
9-cis-retinol
|
Stitch
|
1.088E-11
|
1.761E-8
|
1.901E-7
|
2.993E-7
|
21
|
357
|
18
|
C116926
|
rofecoxib
|
CTD
|
2.525E-11
|
3.859E-8
|
4.168E-7
|
6.947E-7
|
13
|
112
|
19
|
D008769
|
Methylnitronitrosoguanidine
|
CTD
|
2.925E-11
|
4.236E-8
|
4.575E-7
|
8.049E-7
|
18
|
263
|
20
|
D019808
|
Losartan
|
CTD
|
5.283E-11
|
7.268E-8
|
7.849E-7
|
1.454E-6
|
14
|
145
|
21
|
D010656
|
Phenylephrine
|
CTD
|
1.517E-10
|
1.987E-7
|
2.146E-6
|
4.173E-6
|
23
|
500
|
22
|
CID000003961
|
losartan
|
Stitch
|
2.274E-10
|
2.844E-7
|
3.072E-6
|
6.257E-6
|
20
|
378
|
23
|
CID000006124
|
dimethylnitrosamine
|
Stitch
|
2.922E-10
|
3.496E-7
|
3.775E-6
|
8.040E-6
|
15
|
196
|
24
|
D013196
|
Dihydrotestosterone
|
CTD
|
3.880E-10
|
4.449E-7
|
4.805E-6
|
1.068E-5
|
19
|
348
|
25
|
C014464
|
3,4-dichloroaniline
|
CTD
|
4.802E-10
|
5.285E-7
|
5.708E-6
|
1.321E-5
|
14
|
171
|
26
|
C031721
|
naphthalene
|
CTD
|
5.133E-10
|
5.432E-7
|
5.867E-6
|
1.412E-5
|
20
|
396
|
27
|
CID000073587
|
Iamin
|
Stitch
|
6.897E-10
|
7.029E-7
|
7.591E-6
|
1.898E-5
|
8
|
35
|
28
|
CID000001647
|
BAPN
|
Stitch
|
7.629E-10
|
7.497E-7
|
8.096E-6
|
2.099E-5
|
10
|
71
|
29
|
CID000005090
|
rofecoxib
|
Stitch
|
1.395E-9
|
1.323E-6
|
1.429E-5
|
3.837E-5
|
12
|
125
|
30
|
D014284
|
Triiodothyronine
|
CTD
|
1.565E-9
|
1.435E-6
|
1.550E-5
|
4.305E-5
|
21
|
468
|
31
|
D002762
|
Cholecalciferol
|
CTD
|
1.867E-9
|
1.657E-6
|
1.789E-5
|
5.136E-5
|
15
|
224
|
32
|
C011669
|
ascorbate-2-phosphate
|
CTD
|
2.245E-9
|
1.930E-6
|
2.084E-5
|
6.176E-5
|
6
|
15
|
33
|
C500085
|
muraglitazar
|
CTD
|
3.151E-9
|
2.627E-6
|
2.837E-5
|
8.669E-5
|
20
|
440
|
34
|
C506614
|
PD 0325901
|
CTD
|
3.660E-9
|
2.962E-6
|
3.199E-5
|
1.007E-4
|
11
|
108
|
35
|
C533894
|
LG 100815
|
CTD
|
6.536E-9
|
5.136E-6
|
5.547E-5
|
1.799E-4
|
10
|
88
|
36
|
C013172
|
gamma-oryzanol
|
CTD
|
6.719E-9
|
5.136E-6
|
5.547E-5
|
1.849E-4
|
5
|
9
|
37
|
CID000108062
|
Madecassol
|
Stitch
|
7.028E-9
|
5.227E-6
|
5.645E-5
|
1.934E-4
|
8
|
46
|
38
|
C062198
|
octa-2,4,6-trienoic acid
|
CTD
|
7.307E-9
|
5.291E-6
|
5.714E-5
|
2.011E-4
|
10
|
89
|
39
|
CID000000159
|
prostacyclin sodium salt
|
Stitch
|
8.323E-9
|
5.872E-6
|
6.342E-5
|
2.290E-4
|
15
|
250
|
40
|
C577942
|
2-methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide
|
CTD
|
9.138E-9
|
6.143E-6
|
6.634E-5
|
2.514E-4
|
7
|
31
|
41
|
C113580
|
U 0126
|
CTD
|
9.292E-9
|
6.143E-6
|
6.634E-5
|
2.557E-4
|
19
|
422
|
42
|
7094 DN
|
lomustine; Down 200; 100uM; PC3; HT HG-U133A
|
Broad Institute CMAP
|
9.376E-9
|
6.143E-6
|
6.634E-5
|
2.580E-4
|
13
|
180
|
43
|
C581572
|
1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea
|
CTD
|
1.001E-8
|
6.405E-6
|
6.917E-5
|
2.754E-4
|
8
|
48
|
44
|
CID000025476
|
Hypertensin II
|
Stitch
|
1.211E-8
|
7.573E-6
|
8.178E-5
|
3.332E-4
|
19
|
429
|
45
|
D019319
|
Okadaic Acid
|
CTD
|
1.271E-8
|
7.773E-6
|
8.395E-5
|
3.498E-4
|
15
|
258
|
46
|
CID000008534
|
alizarin red S
|
Stitch
|
1.386E-8
|
8.291E-6
|
8.954E-5
|
3.814E-4
|
10
|
95
|
47
|
C583074
|
4,4'-hexafluorisopropylidene diphenol
|
CTD
|
1.455E-8
|
8.507E-6
|
9.188E-5
|
4.004E-4
|
11
|
123
|
48
|
CID000000229
|
arabinopyranose
|
Stitch
|
1.484E-8
|
8.507E-6
|
9.188E-5
|
4.084E-4
|
15
|
261
|
49
|
CID000094284
|
L-3,4-dehydroproline
|
Stitch
|
1.836E-8
|
1.031E-5
|
1.114E-4
|
5.053E-4
|
9
|
73
|
50
|
CID000001318
|
1,10-phenanthroline
|
Stitch
|
2.010E-8
|
1.092E-5
|
1.180E-4
|
5.531E-4
|
15
|
267
|
Show 45 more annotations
|
18: Disease [Display Chart]
2686 annotations before applied cutoff / 16150 genes in category
|
|